≡ Risteys
R14

Documentation Changelog GitHub Contact & Feedback
info icon

Diving or jumping into water causing injury other than drowning or submersion

Endpoint Browser

VWXY20_DIVING_JUMPI_WATER_CAUSI_INJURY_OTHER_DROWN_SUBME

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps

FinnGen

Phenotype data

519870

1. Apply sex-specific rule

None

519870

2. Check conditions

None

519870

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — W16
  • Cause of death: ICD-10 — W16

2 out of 7 registries used, show all original rules.

191

4. Check minimum number of events

None

191

5. Include endpoints

None

191

6. Filter based on genotype QC (FinnGen only)

184

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy
5
First used in FinnGen datafreeze
DF4
Parent code in ICD-10
W[0-1]

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

All Female Male
Number of individuals 184 58 126
Unadjusted period prevalence (%) 0.05 0.02 0.06
Median age at first event (years) 38.58 35.89 39.82

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
191
Matched controls
1910
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
W16
ICD-10 Finland
Diving or jumping into water causing injury other than drowning or submersion
+∞
257.2
184
*
S12.2
ICD-10 Finland
Fracture of other specified cervical vertebra
113.3
27.5
29
*
T91.3
ICD-10 Finland
Sequelae of injury of spinal cord
247.1
22.1
22
*
NA1AA
NOMESCO Finland
Cervical spine X-ray examination without contrast
9.9
21.2
26
30
X59
ICD-10 Finland
Exposure to unspecified factor
4.2
19.8
75
255
X58
ICD-10 Finland
Exposure to other specified factors
3.7
14.9
61
214
S13.4
ICD-10 Finland
Sprain and strain of cervical spine
6.4
14.6
26
46
T70.3
ICD-10 Finland
Caisson disease [decompression sickness]
+∞
11.6
11
*
S43.0
ICD-10 Finland
Dislocation of shoulder joint
5.8
10.9
21
40
W17
ICD-10 Finland
Other fall from one level to another
8.3
10.6
23
31
M03BX01
ATC
baclofen; systemic
14.4
9.9
16
12
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
5.0
9.8
22
48
S14.0
ICD-10 Finland
Concussion and oedema of cervical spinal cord
58.0
9.8
11
*
NAJ10
NOMESCO Finland
Anterior reduction of fracture of cervical spine
+∞
9.4
9
*
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
2.6
8.7
69
341
XKD06
NOMESCO Finland
Physiologic investigation of micturition
10.2
8.5
16
17
NA1AD
NOMESCO Finland
Cervical spine CT examination
4.7
8.4
20
46
T36
ICD-10 Finland
Poisoning by systemic antibiotics
4.6
8.2
20
47
S06.0
ICD-10 Finland
Concussion
3.2
7.9
34
120
G82.5
ICD-10 Finland
Tetraplegia, unspecified
46.9
7.8
9
*
S12.7
ICD-10 Finland
Multiple fractures of cervical spine
46.9
7.8
9
*
W22
ICD-10 Finland
Striking against or struck by other object(s)
3.4
7.6
30
100
J01MA06
ATC
norfloxacin; oral
3.6
7.6
27
84
TQW40
NOMESCO Finland
Remowal of suture of skin
4.4
7.6
20
50
G95.8
ICD-10 Finland
Other specified diseases of spinal cord
83.2
7.5
8
*
XKC03
NOMESCO Finland
Water cystometry
11.5
7.4
13
12
W19
ICD-10 Finland
Unspecified fall
3.4
7.4
29
96
KA1AE
NOMESCO Finland
Kidney ultrasound examination
9.3
7.2
14
16
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.9
7.1
38
151
N18
ICPC
Paralysis/weakness
17.5
6.8
10
6
W10
ICD-10 Finland
Fall on and from stairs and steps
4.0
6.5
19
51
L12
ICPC
Hand/finger symptom/complaint
2.5
6.1
46
218

TimeCodeWAS

↥

TODO / Current known limitations:

  • Only showing the top 300 codes, because showing all (sometimes 20k) makes the page too slow.
  • Legend / how to read the glyphs.
  • Show details (e.g. Fisher or Chi-square test, LR+, etc.) when clicking on a row.
  • Explanation on the underlying data / how the TimeCodeWAS is done (e.g. matched cases / controls, eligibility).
  • Download CSV.
  • No filters and sorters.
  • Limited amount of endpoints (~400) having TimeCodeWAS data.
  • Cross-links to Risteys lab test pages for lab test codes.
OMOP concept
ln(OR)
%cases with code / %controls with code
2×2 table
General Surgery
2 [38004447]
6.6e-01
7.4e-01
2.9e+00
1.0e+50
3.7e+00
1.6e+00
8.6e-01
cases:26.18%
controls:15.42%
cases:10.47%
controls:5.30%
cases:8.90%
controls:0.52%
cases:38.74%
controls:0.00%
cases:12.57%
controls:0.37%
cases:20.00%
controls:4.65%
cases:27.78%
controls:14.03%
50
294
141
1612
20
101
171
1805
17
10
174
1896
74
0
117
1906
24
7
167
1895
38
88
152
1804
50
249
130
1526
Orthopedic Surgery
20 [38004465]
8.6e-01
1.2e+00
—
1.0e+50
4.3e+00
2.0e+00
9.0e-01
cases:16.75%
controls:7.87%
cases:9.42%
controls:3.10%
—
—
cases:20.42%
controls:0.00%
cases:16.23%
controls:0.26%
cases:21.58%
controls:3.44%
cases:25.56%
controls:12.28%
32
150
159
1756
18
59
173
1847
—
39
0
152
1906
31
5
160
1897
41
65
149
1827
46
218
134
1557
Emergency Room Visit
ER [9203]
9.0e-01
6.7e-01
2.5e+00
—
2.4e+00
1.1e+00
6.2e-01
cases:47.12%
controls:26.60%
cases:19.37%
controls:10.91%
cases:13.61%
controls:1.31%
—
—
cases:13.61%
controls:1.42%
cases:23.68%
controls:9.62%
cases:43.33%
controls:29.18%
90
507
101
1399
37
208
154
1698
26
25
165
1881
—
26
27
165
1875
45
182
145
1710
78
518
102
1257
Physical Medicine And Rehabilitation
25 [38004468]
8.0e-01
9.3e-01
—
—
2.8e+00
2.4e+00
1.5e+00
cases:7.85%
controls:3.67%
cases:3.14%
controls:1.26%
—
—
—
—
cases:5.76%
controls:0.37%
cases:14.21%
controls:1.48%
cases:18.33%
controls:4.68%
15
70
176
1836
6
24
185
1882
—
—
11
7
180
1895
27
28
163
1864
33
83
147
1692
Outpatient Visit
OP [9202]
2.4e-01
3.3e-01
2.1e-01
3.5e+00
1.6e+00
1.1e+00
5.6e-01
cases:61.78%
controls:55.93%
cases:43.98%
controls:36.10%
cases:10.47%
controls:8.66%
cases:18.32%
controls:0.68%
cases:29.32%
controls:7.47%
cases:61.05%
controls:34.30%
cases:77.78%
controls:66.59%
118
1066
73
840
84
688
107
1218
20
165
171
1741
35
13
156
1893
56
142
135
1760
116
649
74
1243
140
1182
40
593
Inpatient Hospital
21 [8717]
3.5e-01
6.6e-01
1.9e+00
1.0e+50
2.2e+00
9.8e-01
5.7e-01
cases:31.94%
controls:24.82%
cases:15.71%
controls:8.81%
cases:4.19%
controls:0.63%
cases:38.74%
controls:0.00%
cases:9.42%
controls:1.16%
cases:19.47%
controls:8.30%
cases:32.22%
controls:21.18%
61
473
130
1433
30
168
161
1738
8
12
183
1894
74
0
117
1906
18
22
173
1880
37
157
153
1735
58
376
122
1399
Otolaryngology
4 [38004449]
-1.3e-01
4.9e-01
2.3e+00
1.0e+50
3.0e+00
1.0e+00
5.9e-01
cases:8.38%
controls:9.39%
cases:4.71%
controls:2.94%
cases:3.14%
controls:0.31%
cases:5.76%
controls:0.00%
cases:5.76%
controls:0.32%
cases:7.37%
controls:2.80%
cases:14.44%
controls:8.56%
16
179
175
1727
9
56
182
1850
6
6
185
1900
11
0
180
1906
11
6
180
1896
14
53
176
1839
26
152
154
1623
Exposure to unspecified factor
X59 [45756412]
—
2.2e+00
—
—
—
2.9e+00
1.1e+00
—
—
cases:3.66%
controls:0.42%
—
—
—
—
—
—
cases:7.37%
controls:0.42%
cases:7.22%
controls:2.65%
—
7
8
184
1898
—
—
—
14
8
176
1884
13
47
167
1728
trimethoprim; oral, parenteral
J01EA01 [21602931]
8.5e-01
2.2e+00
—
—
—
1.5e+00
1.3e+00
cases:5.24%
controls:2.31%
cases:4.71%
controls:0.52%
—
—
—
—
—
—
cases:4.74%
controls:1.11%
cases:9.44%
controls:2.70%
10
44
181
1862
9
10
182
1896
—
—
—
9
21
181
1871
17
48
163
1727
duloxetine; oral
N06AX21 [21604749]
1.6e+00
2.5e+00
—
—
—
—
2.2e+00
cases:3.14%
controls:0.68%
cases:3.14%
controls:0.26%
—
—
—
—
—
—
—
—
cases:5.00%
controls:0.56%
6
13
185
1893
6
5
185
1901
—
—
—
—
9
10
171
1765
Neurology
13 [38004458]
4.9e-01
—
—
1.0e+50
2.1e+00
1.6e+00
1.0e+00
cases:9.42%
controls:5.98%
—
—
—
—
cases:3.66%
controls:0.00%
cases:4.19%
controls:0.53%
cases:12.63%
controls:2.96%
cases:17.78%
controls:7.04%
18
114
173
1792
—
—
7
0
184
1906
8
10
183
1892
24
56
166
1836
32
125
148
1650
clonazepam; oral, parenteral
N03AE01 [21604415]
—
—
—
—
—
2.5e+00
2.1e+00
—
—
—
—
—
—
—
—
—
—
cases:3.16%
controls:0.26%
cases:5.00%
controls:0.62%
—
—
—
—
—
6
5
184
1887
9
11
171
1764
Supplier / Service Provider
OMOP5117446 [33004]
-1.1e+00
—
-1.0e+50
—
—
2.7e+00
3.0e+00
cases:9.95%
controls:24.87%
—
—
cases:0.00%
controls:1.00%
—
—
—
—
cases:5.26%
controls:0.37%
cases:11.67%
controls:0.68%
19
474
172
1432
—
0
19
191
1887
—
—
10
7
180
1885
21
12
159
1763
General Practice
1 [38004446]
5.7e-01
1.0e+00
1.6e+00
1.0e+50
2.5e+00
1.0e+00
5.6e-01
cases:10.99%
controls:6.56%
cases:9.95%
controls:3.88%
cases:3.14%
controls:0.63%
cases:8.38%
controls:0.00%
cases:4.19%
controls:0.37%
cases:11.58%
controls:4.39%
cases:17.78%
controls:10.99%
21
125
170
1781
19
74
172
1832
6
12
185
1894
16
0
175
1906
8
7
183
1895
22
83
168
1809
32
195
148
1580
disulfiram; oral
N07BB01 [21604821]
2.2e+00
—
—
—
—
—
2.3e+00
cases:3.14%
controls:0.37%
—
—
—
—
—
—
—
—
—
—
cases:3.89%
controls:0.39%
6
7
185
1899
—
—
—
—
—
7
7
173
1768
Neurosurgery
14 [38004459]
7.4e-01
—
—
1.0e+50
1.0e+50
2.4e+00
1.5e+00
cases:3.66%
controls:1.78%
—
—
—
—
cases:5.76%
controls:0.00%
cases:3.66%
controls:0.00%
cases:6.32%
controls:0.58%
cases:6.67%
controls:1.63%
7
34
184
1872
—
—
11
0
180
1906
7
0
184
1902
12
11
178
1881
12
29
168
1746
pregabalin; oral
N02BF02 [955152]
9.0e-01
—
—
—
—
2.0e+00
1.8e+00
cases:3.66%
controls:1.52%
—
—
—
—
—
—
—
—
cases:5.26%
controls:0.74%
cases:9.44%
controls:1.69%
7
29
184
1877
—
—
—
—
10
14
180
1878
17
30
163
1745
Physiotherapist
Z3226 [2001311560]
7.1e-01
—
—
1.0e+50
—
2.2e+00
1.5e+00
cases:3.66%
controls:1.84%
—
—
—
—
cases:2.62%
controls:0.00%
—
—
cases:3.68%
controls:0.42%
cases:6.11%
controls:1.46%
7
35
184
1871
—
—
5
0
186
1906
—
7
8
183
1884
11
26
169
1749
Hand Surgery
40 [38004480]
—
—
—
—
—
2.3e+00
1.3e+00
—
—
—
—
—
—
—
—
—
—
cases:4.74%
controls:0.48%
cases:8.33%
controls:2.48%
—
—
—
—
—
9
9
181
1883
15
44
165
1731
ibuprofen; oral, parenteral, rectal
M01AE01 [21603967]
2.4e-01
3.7e-01
1.1e+00
—
2.1e+00
6.9e-01
6.1e-01
cases:33.51%
controls:28.38%
cases:19.37%
controls:14.27%
cases:4.71%
controls:1.57%
—
—
cases:15.18%
controls:2.05%
cases:23.16%
controls:13.16%
cases:51.67%
controls:36.79%
64
541
127
1365
37
272
154
1634
9
30
182
1876
—
29
39
162
1863
44
249
146
1643
93
653
87
1122
ibuprofen
R02AX02 [1588667]
2.4e-01
3.7e-01
1.1e+00
—
2.1e+00
6.9e-01
6.1e-01
cases:33.51%
controls:28.38%
cases:19.37%
controls:14.27%
cases:4.71%
controls:1.57%
—
—
cases:15.18%
controls:2.05%
cases:23.16%
controls:13.16%
cases:51.67%
controls:36.79%
64
541
127
1365
37
272
154
1634
9
30
182
1876
—
29
39
162
1863
44
249
146
1643
93
653
87
1122
Office Visit
OMOP4822458 [581477]
-1.3e-01
1.3e-01
—
—
3.4e+00
9.2e-01
6.3e-01
cases:6.81%
controls:7.66%
cases:3.14%
controls:2.78%
—
—
—
—
cases:7.33%
controls:0.26%
cases:6.84%
controls:2.85%
cases:12.78%
controls:7.21%
13
146
178
1760
6
53
185
1853
—
—
14
5
177
1897
13
54
177
1838
23
128
157
1647
Physiotherapy
R4110 [2001310233]
5.7e-01
—
—
1.0e+50
—
1.8e+00
1.5e+00
cases:4.19%
controls:2.41%
—
—
—
—
cases:3.66%
controls:0.00%
—
—
cases:5.26%
controls:0.95%
cases:7.78%
controls:1.92%
8
46
183
1860
—
—
7
0
184
1906
—
10
18
180
1874
14
34
166
1741
Fall on same level from slipping, tripping and stumbling
W01 [45756243]
9.3e-01
—
—
—
—
2.2e+00
1.0e+00
cases:5.76%
controls:2.36%
—
—
—
—
—
—
—
—
cases:5.26%
controls:0.63%
cases:8.33%
controls:3.15%
11
45
180
1861
—
—
—
—
10
12
180
1880
15
56
165
1719
Outpatient Hospital
22 [8756]
4.9e-01
5.9e-01
—
1.0e+50
2.1e+00
1.1e+00
5.9e-01
cases:24.61%
controls:16.63%
cases:9.95%
controls:5.77%
—
—
cases:25.13%
controls:0.00%
cases:5.76%
controls:0.74%
cases:13.68%
controls:5.18%
cases:24.44%
controls:15.21%
47
317
144
1589
19
110
172
1796
—
48
0
143
1906
11
14
180
1888
26
98
164
1794
44
270
136
1505
Laboratory Visit
OMOP4822461 [32036]
7.1e-02
4.4e-03
5.1e-01
3.1e+00
2.2e-01
5.7e-02
9.0e-02
cases:19.90%
controls:18.78%
cases:18.32%
controls:18.26%
cases:7.85%
controls:4.88%
cases:5.76%
controls:0.26%
cases:6.81%
controls:5.52%
cases:20.53%
controls:19.61%
cases:37.22%
controls:35.15%
38
358
153
1548
35
348
156
1558
15
93
176
1813
11
5
180
1901
13
105
178
1797
39
371
151
1521
67
624
113
1151
Exposure to other specified factors
X58 [45756411]
1.3e+00
—
—
—
—
3.0e+00
1.2e+00
cases:3.66%
controls:1.05%
—
—
—
—
—
—
—
—
cases:5.26%
controls:0.26%
cases:6.11%
controls:1.92%
7
20
184
1886
—
—
—
—
10
5
180
1887
11
34
169
1741
Case Management Agency
251B00000X [38004193]
-4.3e-02
1.8e-01
5.3e-01
3.0e+00
5.3e-01
3.1e-01
4.4e-02
cases:39.27%
controls:40.29%
cases:36.13%
controls:32.16%
cases:19.37%
controls:12.43%
cases:14.14%
controls:0.79%
cases:20.42%
controls:13.14%
cases:43.68%
controls:36.15%
cases:60.56%
controls:59.49%
75
768
116
1138
69
613
122
1293
37
237
154
1669
27
15
164
1891
39
250
152
1652
83
684
107
1208
109
1056
71
719
Urology
34 [38004474]
6.4e-01
1.3e+00
—
—
—
1.7e+00
1.1e+00
cases:5.24%
controls:2.83%
cases:4.71%
controls:1.31%
—
—
—
—
—
—
cases:7.89%
controls:1.48%
cases:12.78%
controls:4.51%
10
54
181
1852
9
25
182
1881
—
—
—
15
28
175
1864
23
80
157
1695
Pharmacy visit
OMOP4822462 [581458]
1.7e-01
-7.8e-02
1.6e-01
1.7e+00
1.0e+00
3.5e-01
9.4e-01
cases:90.58%
controls:89.03%
cases:69.63%
controls:71.25%
cases:34.03%
controls:30.54%
cases:5.76%
controls:1.10%
cases:51.83%
controls:28.29%
cases:79.47%
controls:73.20%
cases:96.67%
controls:91.89%
173
1697
18
209
133
1358
58
548
65
582
126
1324
11
21
180
1885
99
538
92
1364
151
1385
39
507
174
1631
6
144
oxazepam; oral
N05BA04 [21604569]
9.5e-01
1.0e+00
—
—
—
1.5e+00
1.2e+00
cases:6.28%
controls:2.52%
cases:3.66%
controls:1.36%
—
—
—
—
—
—
cases:5.26%
controls:1.27%
cases:8.33%
controls:2.70%
12
48
179
1858
7
26
184
1880
—
—
—
10
24
180
1868
15
48
165
1727
ciprofloxacin; oral, parenteral
J01MA02 [21603009]
6.2e-01
6.6e-01
—
—
—
1.3e+00
1.3e+00
cases:8.38%
controls:4.67%
cases:2.62%
controls:1.36%
—
—
—
—
—
—
cases:6.32%
controls:1.74%
cases:13.89%
controls:4.39%
16
89
175
1817
5
26
186
1880
—
—
—
12
33
178
1859
25
78
155
1697
Medication/prescr/renewal
-50 [2002000121]
—
—
—
—
—
—
2.5e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:3.89%
controls:0.34%
—
—
—
—
—
—
7
6
173
1769
calcium (different salts in combination); oral
A12AA20 [21600872]
9.0e-01
9.1e-01
—
—
—
1.4e+00
1.0e+00
cases:5.24%
controls:2.20%
cases:4.71%
controls:1.94%
—
—
—
—
—
—
cases:6.84%
controls:1.85%
cases:8.89%
controls:3.32%
10
42
181
1864
9
37
182
1869
—
—
—
13
35
177
1857
16
59
164
1716
codeine and paracetamol
N02AJ06 [1123647]
4.4e-01
7.2e-01
—
—
2.3e+00
6.0e-01
3.1e-01
cases:10.99%
controls:7.40%
cases:6.28%
controls:3.15%
—
—
—
—
cases:5.24%
controls:0.53%
cases:7.37%
controls:4.18%
cases:16.11%
controls:12.34%
21
141
170
1765
12
60
179
1846
—
—
10
10
181
1892
14
79
176
1813
29
219
151
1556
Rehabilitation Hospital
283X00000X [38004285]
-1.0e+50
—
—
—
—
—
2.3e+00
cases:0.00%
controls:0.26%
—
—
—
—
—
—
—
—
—
—
cases:3.89%
controls:0.39%
0
5
191
1901
—
—
—
—
—
7
7
173
1768
paracetamol; oral, parenteral, rectal
N02BE01 [21604344]
1.3e-01
4.4e-01
7.5e-01
—
2.3e+00
6.0e-01
3.9e-01
cases:19.37%
controls:17.42%
cases:10.99%
controls:7.35%
cases:2.62%
controls:1.26%
—
—
cases:10.47%
controls:1.21%
cases:14.74%
controls:8.67%
cases:33.89%
controls:25.80%
37
332
154
1574
21
140
170
1766
5
24
186
1882
—
20
23
171
1879
28
164
162
1728
61
458
119
1317
buprenorphine; parenteral, sublingual, transdermal
N02AE01 [21604287]
—
—
—
—
—
—
2.2e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:3.33%
controls:0.39%
—
—
—
—
—
—
6
7
174
1768
diclofenac; oral, parenteral, rectal
M01AB05 [21603945]
5.8e-01
6.3e-01
—
—
2.1e+00
6.2e-01
4.5e-01
cases:20.94%
controls:12.91%
cases:7.33%
controls:4.04%
—
—
—
—
cases:4.71%
controls:0.58%
cases:7.37%
controls:4.12%
cases:21.11%
controls:14.59%
40
246
151
1660
14
77
177
1829
—
—
9
11
182
1891
14
78
176
1814
38
259
142
1516
tizanidine; oral
M03BX02 [21604116]
2.4e-01
5.6e-01
—
—
2.0e+00
8.4e-01
6.4e-01
cases:14.14%
controls:11.44%
cases:6.28%
controls:3.67%
—
—
—
—
cases:3.14%
controls:0.42%
cases:10.00%
controls:4.60%
cases:22.22%
controls:13.13%
27
218
164
1688
12
70
179
1836
—
—
6
8
185
1894
19
87
171
1805
40
233
140
1542
lamotrigine; oral
N03AX09 [21604431]
-1.0e+50
—
—
—
—
—
2.0e+00
cases:0.00%
controls:0.42%
—
—
—
—
—
—
—
—
—
—
cases:3.33%
controls:0.45%
0
8
191
1898
—
—
—
—
—
6
8
174
1767
nitrofurantoin; oral
J01XE01 [21603058]
1.2e+00
—
—
—
—
-1.0e+50
1.9e+00
cases:2.62%
controls:0.84%
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.26%
cases:6.11%
controls:0.96%
5
16
186
1890
—
—
—
—
0
5
190
1887
11
17
169
1758
Home Visit
OMOP4822459 [581476]
8.3e-01
—
—
—
—
1.8e+00
5.9e-01
cases:2.62%
controls:1.15%
—
—
—
—
—
—
—
—
cases:4.21%
controls:0.74%
cases:5.56%
controls:3.15%
5
22
186
1884
—
—
—
—
8
14
182
1878
10
56
170
1719
cefalexin; oral
J01DB01 [21602870]
1.1e-01
4.8e-01
—
—
1.8e+00
5.4e-01
5.2e-01
cases:28.27%
controls:26.08%
cases:13.09%
controls:8.55%
—
—
—
—
cases:4.19%
controls:0.74%
cases:14.21%
controls:8.77%
cases:40.00%
controls:28.45%
54
497
137
1409
25
163
166
1743
—
—
8
14
183
1888
27
166
163
1726
72
505
108
1270
Urinary frequency/urgency
U02 [2002001138]
—
—
—
—
—
—
1.8e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:5.00%
controls:0.90%
—
—
—
—
—
—
9
16
171
1759
Day surgery
ZXD20 [2001311388]
1.7e+00
—
—
—
—
—
—
cases:4.19%
controls:0.79%
—
—
—
—
—
—
—
—
—
—
—
—
8
15
183
1891
—
—
—
—
—
—
Hand/finger symptom/complaint
L12 [2002000636]
9.3e-01
—
—
—
—
—
1.6e+00
cases:2.62%
controls:1.05%
—
—
—
—
—
—
—
—
—
—
cases:6.67%
controls:1.41%
5
20
186
1886
—
—
—
—
—
12
25
168
1750
C reactive protein [Mass/volume] in Serum or Plasma
1988-5 [3020460]
9.9e-02
-5.6e-02
—
—
1.5e+00
4.3e-01
3.1e-01
cases:13.61%
controls:12.49%
cases:8.38%
controls:8.81%
—
—
—
—
cases:5.76%
controls:1.31%
cases:12.63%
controls:8.62%
cases:26.67%
controls:21.01%
26
238
165
1668
16
168
175
1738
—
—
11
25
180
1877
24
163
166
1729
48
373
132
1402
norfloxacin; oral
J01MA06 [21603013]
1.5e+00
—
—
—
—
—
1.5e+00
cases:4.71%
controls:1.10%
—
—
—
—
—
—
—
—
—
—
cases:4.44%
controls:1.01%
9
21
182
1885
—
—
—
—
—
8
18
172
1757
quetiapine; oral
N05AH04 [21604544]
9.4e-01
1.4e+00
—
—
—
1.4e+00
8.3e-01
cases:4.19%
controls:1.68%
cases:4.71%
controls:1.21%
—
—
—
—
—
—
cases:5.79%
controls:1.53%
cases:6.11%
controls:2.76%
8
32
183
1874
9
23
182
1883
—
—
—
11
29
179
1863
11
49
169
1726
mirtazapine; oral
N06AX11 [21604740]
7.8e-01
6.7e-01
—
—
—
1.3e+00
7.9e-01
cases:5.24%
controls:2.47%
cases:3.14%
controls:1.63%
—
—
—
—
—
—
cases:6.32%
controls:1.80%
cases:9.44%
controls:4.51%
10
47
181
1859
6
31
185
1875
—
—
—
12
34
178
1858
17
80
163
1695
orphenadrine (citrate); oral, parenteral
M03BC01 [21604112]
5.3e-01
5.9e-01
—
—
—
—
1.3e+00
cases:7.85%
controls:4.77%
cases:2.62%
controls:1.47%
—
—
—
—
—
—
—
—
cases:16.11%
controls:5.01%
15
91
176
1815
5
28
186
1878
—
—
—
—
29
89
151
1686
orphenadrine (chloride); oral, parenteral
N04AB02 [21604458]
5.3e-01
5.9e-01
—
—
—
—
1.3e+00
cases:7.85%
controls:4.77%
cases:2.62%
controls:1.47%
—
—
—
—
—
—
—
—
cases:16.11%
controls:5.01%
15
91
176
1815
5
28
186
1878
—
—
—
—
29
89
151
1686
Psychiatry
26 [38004469]
6.7e-01
1.1e+00
—
—
1.4e+00
1.2e+00
6.5e-01
cases:8.38%
controls:4.46%
cases:6.28%
controls:2.15%
—
—
—
—
cases:3.66%
controls:0.89%
cases:7.89%
controls:2.48%
cases:11.67%
controls:6.42%
16
85
175
1821
12
41
179
1865
—
—
7
17
184
1885
15
47
175
1845
21
114
159
1661
zolpidem; oral
N05CF02 [21604655]
8.6e-01
1.2e+00
—
—
—
7.9e-01
1.2e+00
cases:4.71%
controls:2.05%
cases:3.14%
controls:0.94%
—
—
—
—
—
—
cases:2.63%
controls:1.22%
cases:7.22%
controls:2.31%
9
39
182
1867
6
18
185
1888
—
—
—
5
23
185
1869
13
41
167
1734
pivmecillinam; oral
J01CA08 [21602827]
3.2e-01
—
—
—
—
1.1e+00
1.2e+00
cases:4.71%
controls:3.46%
—
—
—
—
—
—
—
—
cases:4.21%
controls:1.43%
cases:11.67%
controls:4.00%
9
66
182
1840
—
—
—
—
8
27
182
1865
21
71
159
1704
tramadol; oral, parenteral, rectal
N02AX02 [21604298]
6.4e-01
3.6e-01
—
—
—
6.6e-01
1.1e+00
cases:9.42%
controls:5.19%
cases:3.14%
controls:2.20%
—
—
—
—
—
—
cases:4.21%
controls:2.22%
cases:14.44%
controls:5.52%
18
99
173
1807
6
42
185
1864
—
—
—
8
42
182
1850
26
98
154
1677
Medical doctor
Z2221 [2001311556]
2.1e-01
—
—
1.0e+50
—
9.7e-01
1.0e+00
cases:4.19%
controls:3.41%
—
—
—
—
cases:3.14%
controls:0.00%
—
—
cases:3.68%
controls:1.43%
cases:8.33%
controls:3.10%
8
65
183
1841
—
—
6
0
185
1906
—
7
27
183
1865
15
55
165
1720
Albumin [Presence] in Urine by Test strip
50949-7 [3029937]
7.9e-01
—
—
—
—
1.1e+00
1.0e+00
cases:4.19%
controls:1.94%
—
—
—
—
—
—
—
—
cases:3.68%
controls:1.27%
cases:8.89%
controls:3.32%
8
37
183
1869
—
—
—
—
7
24
183
1868
16
59
164
1716
zopiclone; oral
N05CF01 [21604654]
2.5e-01
2.7e-01
—
—
—
4.7e-01
9.2e-01
cases:5.24%
controls:4.14%
cases:3.14%
controls:2.41%
—
—
—
—
—
—
cases:3.68%
controls:2.33%
cases:10.56%
controls:4.51%
10
79
181
1827
6
46
185
1860
—
—
—
7
44
183
1848
19
80
161
1695
Upper gastrointestinal surgery
106 [44777669]
4.5e-01
4.7e-01
—
—
—
1.1e+00
8.7e-01
cases:6.81%
controls:4.46%
cases:3.14%
controls:1.99%
—
—
—
—
—
—
cases:4.74%
controls:1.59%
cases:11.67%
controls:5.24%
13
85
178
1821
6
38
185
1868
—
—
—
9
30
181
1862
21
93
159
1682
Bacteria [#/volume] in Urine by Automated count
51480-2 [3031040]
-1.3e-02
2.3e-01
—
—
1.5e+00
2.8e-01
8.0e-01
cases:5.24%
controls:5.30%
cases:4.19%
controls:3.36%
—
—
—
—
cases:3.14%
controls:0.68%
cases:4.21%
controls:3.22%
cases:17.22%
controls:8.56%
10
101
181
1805
8
64
183
1842
—
—
6
13
185
1889
8
61
182
1831
31
152
149
1623
Telehealth
OMOP5556618 [722455]
1.6e-01
6.7e-01
1.3e+00
—
7.9e-01
6.0e-01
6.1e-01
cases:15.18%
controls:13.22%
cases:9.42%
controls:5.04%
cases:3.14%
controls:0.84%
—
—
cases:2.62%
controls:1.21%
cases:8.95%
controls:5.13%
cases:26.11%
controls:16.06%
29
252
162
1654
18
96
173
1810
6
16
185
1890
—
5
23
186
1879
17
97
173
1795
47
285
133
1490
Thorax X-ray examination
GD1AA [2001303617]
6.3e-01
—
—
1.0e+50
—
—
2.1e-01
cases:5.76%
controls:3.15%
—
—
—
—
cases:5.24%
controls:0.00%
—
—
—
—
cases:6.11%
controls:5.01%
11
60
180
1846
—
—
10
0
181
1906
—
—
11
89
169
1686
insulin glulisine; parenteral
A10AB06 [21600720]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.28%
—
—
—
—
—
—
0
5
180
1770
Besnier prurigo
L20.0 [45562534]
—
-1.0e+50
—
—
—
-1.0e+50
—
—
—
cases:0.00%
controls:0.47%
—
—
—
—
—
—
cases:0.00%
controls:0.32%
—
—
—
0
9
191
1897
—
—
—
0
6
190
1886
—
Parainfluenza type 3 nucleic acid detection
222361000000104 [44790049]
—
-1.0e+50
—
—
—
-1.0e+50
—
—
—
cases:0.00%
controls:0.26%
—
—
—
—
—
—
cases:0.00%
controls:0.26%
—
—
—
0
5
191
1901
—
—
—
0
5
190
1887
—
Corns and callosities
L84 [45533651]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.34%
—
—
—
—
—
—
0
6
180
1769
Procedure duration 120 to 149 minutes
ZXE15 [2001311406]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.26%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
191
1901
—
—
—
—
—
—
Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
21573-1 [3003031]
8.1e-01
-1.0e+50
—
—
—
-1.0e+50
8.2e-01
cases:3.14%
controls:1.42%
cases:0.00%
controls:0.84%
—
—
—
—
—
—
cases:0.00%
controls:0.58%
cases:3.89%
controls:1.75%
6
27
185
1879
0
16
191
1890
—
—
—
0
11
190
1881
7
31
173
1744
Heartburn
R12 [45539318]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.37%
—
—
—
—
—
—
—
—
—
—
—
—
0
7
191
1899
—
—
—
—
—
—
dextromethorphan; oral
R05DA09 [21603404]
3.2e-01
-1.0e+50
—
—
—
—
—
cases:3.66%
controls:2.68%
cases:0.00%
controls:0.42%
—
—
—
—
—
—
—
—
—
—
7
51
184
1855
0
8
191
1898
—
—
—
—
—
glucosamine; oral
M01AX05 [21604002]
—
—
—
—
—
—
2.7e-01
—
—
—
—
—
—
—
—
—
—
—
—
cases:2.78%
controls:2.14%
—
—
—
—
—
—
5
38
175
1737
Interscalenous plexus blockade
WX200 [2001310777]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.28%
—
—
—
—
—
—
0
5
180
1770
Reticulocytes [#/volume] in Blood
14196-0 [3023520]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.26%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
191
1901
—
—
—
—
—
—
Malignant neoplasm of prostate
C61 [45547509]
—
—
-1.0e+50
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.31%
—
—
—
—
—
—
—
—
—
—
0
6
191
1900
—
—
—
—
25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
68438-1 [40771025]
—
—
—
—
—
—
5.4e-01
—
—
—
—
—
—
—
—
—
—
—
—
cases:9.44%
controls:5.75%
—
—
—
—
—
—
17
102
163
1673
Sensorineural hearing loss, bilateral
H90.3 [45576850]
-1.0e+50
-1.0e+50
—
—
—
-1.0e+50
-1.0e+50
cases:0.00%
controls:1.05%
cases:0.00%
controls:0.37%
—
—
—
—
—
—
cases:0.00%
controls:0.32%
cases:0.00%
controls:0.85%
0
20
191
1886
0
7
191
1899
—
—
—
0
6
190
1886
0
15
180
1760
Small restoration
SFA00 [2001310357]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.63%
—
—
—
—
—
—
—
—
—
—
—
—
0
12
191
1894
—
—
—
—
—
—
ezetimibe; oral
C10AX09 [21601896]
—
-1.0e+50
—
—
—
-1.0e+50
4.1e-01
—
—
cases:0.00%
controls:0.68%
—
—
—
—
—
—
cases:0.00%
controls:0.58%
cases:2.78%
controls:1.86%
—
0
13
191
1893
—
—
—
0
11
190
1881
5
33
175
1742
Hypothyroidism, unspecified
E03.9 [45537945]
-1.0e+50
-1.0e+50
—
—
—
-1.0e+50
—
cases:0.00%
controls:0.63%
cases:0.00%
controls:0.37%
—
—
—
—
—
—
cases:0.00%
controls:0.37%
—
—
0
12
191
1894
0
7
191
1899
—
—
—
0
7
190
1885
—
mirabegron; oral
G04BD12 [43534790]
—
—
—
—
—
—
1.6e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:2.78%
controls:0.56%
—
—
—
—
—
—
5
10
175
1765
Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method
4537-7 [3013707]
3.0e-01
-1.5e-02
-1.0e+50
—
—
-1.8e-01
2.9e-01
cases:8.90%
controls:6.77%
cases:4.19%
controls:4.25%
cases:0.00%
controls:0.84%
—
—
—
—
cases:3.68%
controls:4.39%
cases:14.44%
controls:11.21%
17
129
174
1777
8
81
183
1825
0
16
191
1890
—
—
7
83
183
1809
26
199
154
1576
tolfenamic acid; oral, rectal
M01AG02 [21603988]
—
-1.0e+50
—
—
—
—
—
—
—
cases:0.00%
controls:0.31%
—
—
—
—
—
—
—
—
—
—
—
0
6
191
1900
—
—
—
—
—
Knee symptom/complaint
L15 [2002000639]
—
-1.0e+50
—
—
—
—
—
—
—
cases:0.00%
controls:0.37%
—
—
—
—
—
—
—
—
—
—
—
0
7
191
1899
—
—
—
—
—
Osmolality of Urine
2695-5 [3026782]
—
-1.0e+50
—
—
—
—
7.9e-01
—
—
cases:0.00%
controls:1.00%
—
—
—
—
—
—
—
—
cases:3.89%
controls:1.80%
—
0
19
191
1887
—
—
—
—
7
32
173
1743
candesartan and diuretics
C09DA06 [21601838]
-1.0e+50
-1.0e+50
—
—
—
-1.0e+50
—
cases:0.00%
controls:0.79%
cases:0.00%
controls:0.68%
—
—
—
—
—
—
cases:0.00%
controls:0.74%
—
—
0
15
191
1891
0
13
191
1893
—
—
—
0
14
190
1878
—
Outlet vacuum delivery
MAE00 [2001306882]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.26%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
191
1901
—
—
—
—
—
—
Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1920-8 [3013721]
4.8e-01
—
—
—
—
-1.0e+50
5.3e-02
cases:5.24%
controls:3.31%
—
—
—
—
—
—
—
—
cases:0.00%
controls:1.80%
cases:4.44%
controls:4.23%
10
63
181
1843
—
—
—
—
0
34
190
1858
8
75
172
1700
meloxicam; oral, parenteral, rectal
M01AC06 [21603965]
3.7e-01
-1.0e+50
-1.0e+50
—
—
—
4.1e-01
cases:5.76%
controls:4.04%
cases:0.00%
controls:1.15%
cases:0.00%
controls:0.26%
—
—
—
—
—
—
cases:5.56%
controls:3.77%
11
77
180
1829
0
22
191
1884
0
5
191
1901
—
—
—
10
67
170
1708
Neonatal screening
60151004 [4246502]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.31%
—
—
—
—
—
—
—
—
—
—
—
—
0
6
191
1900
—
—
—
—
—
—
betamethasone
C05AA05 [21601610]
4.3e-01
7.0e-01
-1.0e+50
—
—
—
3.2e-01
cases:5.76%
controls:3.83%
cases:2.62%
controls:1.31%
cases:0.00%
controls:0.26%
—
—
—
—
—
—
cases:7.78%
controls:5.75%
11
73
180
1833
5
25
186
1881
0
5
191
1901
—
—
—
14
102
166
1673
Other seropositive rheumatoid arthritis
M05.8 [45538634]
-1.0e+50
-1.0e+50
—
—
—
-1.0e+50
-1.0e+50
cases:0.00%
controls:0.26%
cases:0.00%
controls:0.31%
—
—
—
—
—
—
cases:0.00%
controls:0.32%
cases:0.00%
controls:0.39%
0
5
191
1901
0
6
191
1900
—
—
—
0
6
190
1886
0
7
180
1768
ketoprofen; oral, parenteral, rectal
M01AE03 [21603969]
1.9e-01
—
—
—
—
—
6.7e-02
cases:6.81%
controls:5.72%
—
—
—
—
—
—
—
—
—
—
cases:4.44%
controls:4.17%
13
109
178
1797
—
—
—
—
—
8
74
172
1701
Epithelial cells.non-squamous [#/volume] in Urine by Automated count
51485-1 [3030306]
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.79%
—
—
—
—
—
—
—
0
15
190
1877
—
cefaclor; oral
J01DC04 [21602886]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.58%
—
—
—
—
—
—
—
—
—
—
—
—
0
11
191
1895
—
—
—
—
—
—
cloZAPine [Moles/volume] in Serum or Plasma
14656-3 [3000081]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.28%
—
—
—
—
—
—
0
5
180
1770
Cardiac arrhythmia, unspecified
I49.9 [45581778]
—
-1.0e+50
—
—
—
—
—
—
—
cases:0.00%
controls:0.26%
—
—
—
—
—
—
—
—
—
—
—
0
5
191
1901
—
—
—
—
—
Shoulder extensive X-ray examination without contrast
NB1BA [2001307228]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.26%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
191
1901
—
—
—
—
—
—
Methadone [Presence] in Urine by Screen method
19550-3 [3028707]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.42%
—
—
—
—
—
—
—
—
—
—
—
—
0
8
191
1898
—
—
—
—
—
—
ipratropium bromide; nasal
R01AX03 [21603199]
-1.0e+50
—
—
—
—
—
-1.0e+50
cases:0.00%
controls:0.31%
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.34%
0
6
191
1900
—
—
—
—
—
0
6
180
1769
Procalcitonin [Mass/volume] in Serum or Plasma
33959-8 [3046279]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.28%
—
—
—
—
—
—
0
5
180
1770
Examination and observation for other specified reasons
Z04.8 [45552063]
—
-1.0e+50
—
—
—
—
9.7e-01
—
—
cases:0.00%
controls:0.52%
—
—
—
—
—
—
—
—
cases:2.78%
controls:1.07%
—
0
10
191
1896
—
—
—
—
5
19
175
1756
Neutrophils [#/volume] in Blood by Automated count
751-8 [3013650]
5.2e-02
-2.2e-03
—
—
—
—
3.6e-01
cases:5.24%
controls:4.98%
cases:3.66%
controls:3.67%
—
—
—
—
—
—
—
—
cases:11.11%
controls:8.00%
10
95
181
1811
7
70
184
1836
—
—
—
—
20
142
160
1633
Fetal Trisomy 21 risk [Likelihood] Based on maternal age
49090-4 [3049207]
-1.0e+50
—
—
—
—
—
-1.0e+50
cases:0.00%
controls:0.26%
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.45%
0
5
191
1901
—
—
—
—
—
0
8
180
1767
No disease
A97 [2002000230]
—
-1.0e+50
—
—
—
—
4.3e-01
—
—
cases:0.00%
controls:0.63%
—
—
—
—
—
—
—
—
cases:3.33%
controls:2.20%
—
0
12
191
1894
—
—
—
—
6
39
174
1736
oxycodone; oral, parenteral
N02AA05 [21604260]
—
—
—
—
—
—
1.5e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:3.33%
controls:0.79%
—
—
—
—
—
—
6
14
174
1761
Telephone prescription or other care instructions
WZB00 [2001310884]
2.9e-01
—
—
—
—
—
—
cases:4.71%
controls:3.57%
—
—
—
—
—
—
—
—
—
—
—
—
9
68
182
1838
—
—
—
—
—
—
Tonsillectomy
EMB10 [2001302265]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.79%
—
—
—
—
—
—
—
—
—
—
—
—
0
15
191
1891
—
—
—
—
—
—
Eosinophils [#/volume] in Blood
26449-9 [3013115]
-2.2e-01
1.5e-02
-1.0e+50
—
—
—
7.3e-02
cases:3.66%
controls:4.51%
cases:3.14%
controls:3.10%
cases:0.00%
controls:1.00%
—
—
—
—
—
—
cases:7.78%
controls:7.27%
7
86
184
1820
6
59
185
1847
0
19
191
1887
—
—
—
14
129
166
1646
metformin and sitagliptin
A10BD07 [21600772]
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.42%
—
—
—
—
—
—
—
0
8
190
1884
—
Diverticular disease of small intestine without perforation or abscess
K57.1 [45562500]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.28%
—
—
—
—
—
—
0
5
180
1770
Fracture of calcaneus
S92.0 [45545962]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.28%
—
—
—
—
—
—
0
5
180
1770
levocabastine
S01GX02 [21605086]
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.26%
—
—
—
—
—
—
—
0
5
190
1887
—
Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
1805-1 [3016417]
—
-1.0e+50
—
—
—
-1.0e+50
—
—
—
cases:0.00%
controls:0.42%
—
—
—
—
—
—
cases:0.00%
controls:0.26%
—
—
—
0
8
191
1898
—
—
—
0
5
190
1887
—
simvastatin; oral
C10AA01 [21601856]
—
—
—
—
-1.0e+50
—
-6.9e-01
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.95%
—
—
cases:3.89%
controls:7.49%
—
—
—
—
0
18
191
1884
—
7
133
173
1642
tadalafil; oral
G04BE08 [21602653]
-1.0e+50
-1.0e+50
—
—
—
—
—
cases:0.00%
controls:0.31%
cases:0.00%
controls:0.31%
—
—
—
—
—
—
—
—
—
—
0
6
191
1900
0
6
191
1900
—
—
—
—
—
General psychiatric examination, not elsewhere classified
Z00.4 [45605094]
8.8e-01
—
—
—
—
-1.0e+50
1.2e+00
cases:2.62%
controls:1.10%
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.32%
cases:3.89%
controls:1.24%
5
21
186
1885
—
—
—
—
0
6
190
1886
7
22
173
1753
valproic acid; oral, parenteral, rectal
N03AG01 [21604422]
—
—
—
—
—
—
1.8e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:3.33%
controls:0.56%
—
—
—
—
—
—
6
10
174
1765
Rotator cuff syndrome
M75.1 [45596678]
—
—
—
—
—
—
7.7e-01
—
—
—
—
—
—
—
—
—
—
—
—
cases:5.56%
controls:2.65%
—
—
—
—
—
—
10
47
170
1728
Other chronic renal failure
N18.8 [45534123]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.39%
—
—
—
—
—
—
0
7
180
1768
Headache
N01 [2002000720]
—
-1.0e+50
—
—
—
—
1.3e+00
—
—
cases:0.00%
controls:0.52%
—
—
—
—
—
—
—
—
cases:3.89%
controls:1.13%
—
0
10
191
1896
—
—
—
—
7
20
173
1755
metronidazole
D06BX01 [21602096]
—
-1.0e+50
—
—
—
-1.0e+50
—
—
—
cases:0.00%
controls:0.26%
—
—
—
—
—
—
cases:0.00%
controls:0.48%
—
—
—
0
5
191
1901
—
—
—
0
9
190
1883
—
Monitoring the use of the aid
R5140 [2001310249]
-1.0e+50
-1.0e+50
—
—
—
—
—
cases:0.00%
controls:0.47%
cases:0.00%
controls:0.31%
—
—
—
—
—
—
—
—
—
—
0
9
191
1897
0
6
191
1900
—
—
—
—
—
Asthma, unspecified
J45.9 [45562456]
8.3e-01
-1.0e+50
—
—
—
-1.0e+50
—
cases:3.66%
controls:1.63%
cases:0.00%
controls:0.73%
—
—
—
—
—
—
cases:0.00%
controls:0.85%
—
—
7
31
184
1875
0
14
191
1892
—
—
—
0
16
190
1876
—
Mouth/tongue/lip symptom/complaint
D20 [2002000319]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.26%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
191
1901
—
—
—
—
—
—
Sarcoidosis of lung with sarcoidosis of lymph nodes
D86.2 [45586127]
-1.0e+50
—
—
—
—
—
-1.0e+50
cases:0.00%
controls:0.26%
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.34%
0
5
191
1901
—
—
—
—
—
0
6
180
1769
Blepharitis
H01.0 [45533180]
-1.0e+50
—
—
—
—
—
-1.0e+50
cases:0.00%
controls:0.47%
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.28%
0
9
191
1897
—
—
—
—
—
0
5
180
1770
Feeling anxious/nervous/tense
P01 [2002000798]
1.2e+00
—
—
—
—
—
6.3e-01
cases:2.62%
controls:0.84%
—
—
—
—
—
—
—
—
—
—
cases:3.33%
controls:1.80%
5
16
186
1890
—
—
—
—
—
6
32
174
1743
Local gingivore traction
K06.00 [2000502734]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.28%
—
—
—
—
—
—
0
5
180
1770
Epithelial cells [#/volume] in Urine
30383-4 [3000850]
—
—
—
—
—
—
1.0e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:5.00%
controls:1.86%
—
—
—
—
—
—
9
33
171
1742
Cervical spine CT examination
NA1AD [2001306982]
—
—
—
1.0e+50
—
—
—
—
—
—
—
—
—
cases:4.19%
controls:0.00%
—
—
—
—
—
—
—
—
—
8
0
183
1906
—
—
—
Sciatica
M54.3 [45586994]
-1.0e+50
—
—
—
—
—
-1.0e+50
cases:0.00%
controls:0.42%
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.45%
0
8
191
1898
—
—
—
—
—
0
8
180
1767
Hypertensive heart disease without (congestive) heart failure
I11.9 [45576863]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.28%
—
—
—
—
—
—
0
5
180
1770
Low back symptom/complaint
L03 [2002000628]
1.4e+00
—
—
—
—
—
7.5e-01
cases:4.71%
controls:1.15%
—
—
—
—
—
—
—
—
—
—
cases:5.56%
controls:2.70%
9
22
182
1884
—
—
—
—
—
10
48
170
1727
Hypertrophy of breast
N62 [45577538]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.28%
—
—
—
—
—
—
0
5
180
1770
Respiratory and circulatory monitoring
WX700 [2001310817]
5.5e-01
—
—
1.0e+50
—
—
7.9e-01
cases:2.62%
controls:1.52%
—
—
—
—
cases:5.76%
controls:0.00%
—
—
—
—
cases:3.89%
controls:1.80%
5
29
186
1877
—
—
11
0
180
1906
—
—
7
32
173
1743
ketoprofen, combinations
M01AE53 [21603985]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.26%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
191
1901
—
—
—
—
—
—
Diverticular disease of large intestine without perforation or abscess
K57.3 [45567316]
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.32%
—
—
—
—
—
—
—
0
6
190
1886
—
alfuzosin; oral
G04CA01 [21602668]
-1.0e+50
-1.0e+50
—
—
—
-1.0e+50
—
cases:0.00%
controls:1.00%
cases:0.00%
controls:0.73%
—
—
—
—
—
—
cases:0.00%
controls:0.79%
—
—
0
19
191
1887
0
14
191
1892
—
—
—
0
15
190
1877
—
Operation for phimosis
KGH10 [2001306288]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.31%
—
—
—
—
—
—
—
—
—
—
—
—
0
6
191
1900
—
—
—
—
—
—
Normoblasts [#/volume] in Blood
715-3 [3021589]
-5.3e-02
6.1e-02
—
—
—
3.3e-01
4.3e-01
cases:3.14%
controls:3.31%
cases:2.62%
controls:2.47%
—
—
—
—
—
—
cases:4.21%
controls:3.07%
cases:8.89%
controls:5.97%
6
63
185
1843
5
47
186
1859
—
—
—
8
58
182
1834
16
106
164
1669
Other gastroenteritis and colitis of infectious and unspecified origin
A09 [45605189]
5.2e-01
—
—
—
—
—
3.2e-01
cases:3.14%
controls:1.89%
—
—
—
—
—
—
—
—
—
—
cases:2.78%
controls:2.03%
6
36
185
1870
—
—
—
—
—
5
36
175
1739
cromoglicic acid
S01GX01 [21605085]
5.8e-01
—
—
—
—
—
—
cases:5.24%
controls:2.99%
—
—
—
—
—
—
—
—
—
—
—
—
10
57
181
1849
—
—
—
—
—
—
Ear pain/earache
H01 [2002000475]
—
—
—
—
—
-1.0e+50
9.7e-01
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.42%
cases:2.78%
controls:1.07%
—
—
—
—
—
0
8
190
1884
5
19
175
1756
mometasone
D07AC13 [21602132]
1.7e-01
—
—
—
—
—
6.5e-01
cases:3.66%
controls:3.10%
—
—
—
—
—
—
—
—
—
—
cases:5.56%
controls:2.99%
7
59
184
1847
—
—
—
—
—
10
53
170
1722
Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
32166-1 [3008714]
-1.0e+50
—
—
—
—
—
-1.0e+50
cases:0.00%
controls:0.26%
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.45%
0
5
191
1901
—
—
—
—
—
0
8
180
1767
Chronic apical periodontitis
K04.5 [45586691]
6.3e-01
—
—
—
—
—
7.1e-01
cases:2.62%
controls:1.42%
—
—
—
—
—
—
—
—
—
—
cases:5.56%
controls:2.82%
5
27
186
1879
—
—
—
—
—
10
50
170
1725
Left ventricular failure
I50.1 [45543181]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.26%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
191
1901
—
—
—
—
—
—
Counselling related to known health issue
SPAT1310 [2001700411]
9.7e-01
—
—
—
—
—
-2.5e-01
cases:5.24%
controls:2.05%
—
—
—
—
—
—
—
—
—
—
cases:3.33%
controls:4.23%
10
39
181
1867
—
—
—
—
—
6
75
174
1700
Dilated cardiomyopathy
I42.0 [45586581]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.26%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
191
1901
—
—
—
—
—
—
progesterone; oral, parenteral, rectal, vaginal
G03DA04 [21602542]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.28%
—
—
—
—
—
—
0
5
180
1770
naproxen and esomeprazole; oral
M01AE52 [40254096]
1.0e+00
—
—
—
—
—
1.4e+00
cases:2.62%
controls:0.94%
—
—
—
—
—
—
—
—
—
—
cases:3.89%
controls:1.01%
5
18
186
1888
—
—
—
—
—
7
18
173
1757
Transferrin [Mass/volume] in Serum or Plasma
3034-6 [3004789]
—
-1.0e+50
—
—
—
-1.0e+50
—
—
—
cases:0.00%
controls:0.58%
—
—
—
—
—
—
cases:0.00%
controls:0.58%
—
—
—
0
11
191
1895
—
—
—
0
11
190
1881
—
Caisson disease [decompression sickness]
T70.3 [45599695]
—
—
—
1.0e+50
1.0e+50
—
—
—
—
—
—
—
—
cases:5.76%
controls:0.00%
cases:2.62%
controls:0.00%
—
—
—
—
—
—
—
11
0
180
1906
5
0
186
1902
—
—
theophylline; oral, parenteral, rectal
R03DA04 [21603332]
-1.0e+50
—
—
—
—
—
-1.0e+50
cases:0.00%
controls:0.37%
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.45%
0
7
191
1899
—
—
—
—
—
0
8
180
1767
Erythrocytes [#/volume] in Urine
30391-7 [3002582]
—
—
-1.0e+50
—
—
—
3.7e-01
—
—
—
—
cases:0.00%
controls:0.26%
—
—
—
—
—
—
cases:5.56%
controls:3.89%
—
—
0
5
191
1901
—
—
—
10
69
170
1706
Chronic respiratory failure
J96.1 [45557632]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.34%
—
—
—
—
—
—
0
6
180
1769
Calcium [Moles/volume] corrected for albumin in Serum or Plasma
29265-6 [3020059]
-1.0e+50
-1.0e+50
—
—
—
-1.0e+50
1.3e+00
cases:0.00%
controls:0.58%
cases:0.00%
controls:0.42%
—
—
—
—
—
—
cases:0.00%
controls:0.53%
cases:4.44%
controls:1.30%
0
11
191
1895
0
8
191
1898
—
—
—
0
10
190
1882
8
23
172
1752
Cutaneous abscess, furuncle and carbuncle of trunk
L02.2 [45586751]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.39%
—
—
—
—
—
—
0
7
180
1768
Contusion of finger(s) without damage to nail
S60.0 [45535417]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.28%
—
—
—
—
—
—
0
5
180
1770
Pneumonia, unspecified
J18.9 [45601123]
1.0e+00
—
—
—
—
—
—
cases:3.66%
controls:1.36%
—
—
—
—
—
—
—
—
—
—
—
—
7
26
184
1880
—
—
—
—
—
—
Contusion of thorax
S20.2 [45597402]
—
—
—
1.0e+50
—
—
—
—
—
—
—
—
—
cases:2.62%
controls:0.00%
—
—
—
—
—
—
—
—
—
5
0
186
1906
—
—
—
Moderate depressive episode without somatic syndrome
F32.10 [2000501980]
—
—
—
—
—
—
7.3e-01
—
—
—
—
—
—
—
—
—
—
—
—
cases:2.78%
controls:1.35%
—
—
—
—
—
—
5
24
175
1751
Cortisol [Moles/volume] in Saliva (oral fluid)
51844-9 [3039429]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.28%
—
—
—
—
—
—
0
5
180
1770
furosemide and potassium-sparing agents
C03EB01 [21601554]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.31%
—
—
—
—
—
—
—
—
—
—
—
—
0
6
191
1900
—
—
—
—
—
—
Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
19072-8 [3016431]
-2.6e-01
2.5e-01
—
—
—
6.2e-01
3.8e-01
cases:2.62%
controls:3.36%
cases:2.62%
controls:2.05%
—
—
—
—
—
—
cases:3.68%
controls:2.01%
cases:7.78%
controls:5.46%
5
64
186
1842
5
39
186
1867
—
—
—
7
38
183
1854
14
97
166
1678
Localized swelling, mass and lump, neck
R22.1 [45592412]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.28%
—
—
—
—
—
—
0
5
180
1770
Biopsy of vaginal cervix
LDA20 [2001306656]
-1.0e+50
—
—
—
—
—
-1.0e+50
cases:0.00%
controls:0.47%
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.62%
0
9
191
1897
—
—
—
—
—
0
11
180
1764
Other Crohn disease
K50.8 [45533599]
-1.0e+50
-1.0e+50
—
—
—
-1.0e+50
—
cases:0.00%
controls:0.26%
cases:0.00%
controls:0.31%
—
—
—
—
—
—
cases:0.00%
controls:0.37%
—
—
0
5
191
1901
0
6
191
1900
—
—
—
0
7
190
1885
—
Cholesterol [Moles/volume] in Serum or Plasma
14647-2 [3019900]
1.1e-01
-2.4e-01
—
—
—
-3.6e-01
3.2e-02
cases:10.99%
controls:9.97%
cases:6.28%
controls:7.82%
—
—
—
—
—
—
cases:5.26%
controls:7.35%
cases:21.67%
controls:21.13%
21
190
170
1716
12
149
179
1757
—
—
—
10
139
180
1753
39
375
141
1400
chondroitin sulfate
M01AX25 [21604013]
—
-1.0e+50
—
—
—
—
—
—
—
cases:0.00%
controls:0.31%
—
—
—
—
—
—
—
—
—
—
—
0
6
191
1900
—
—
—
—
—
Cyclic citrullinated peptide Ab [Units/volume] in Serum
53027-9 [3041942]
9.3e-01
-1.0e+50
—
—
—
—
9.6e-01
cases:2.62%
controls:1.05%
cases:0.00%
controls:0.47%
—
—
—
—
—
—
—
—
cases:4.44%
controls:1.75%
5
20
186
1886
0
9
191
1897
—
—
—
—
8
31
172
1744
carbamide
D02AE01 [21601975]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.28%
—
—
—
—
—
—
0
5
180
1770
Psychosocial counselling and guidance
SPAT1307 [2001700408]
—
-1.0e+50
—
—
—
—
-1.0e+50
—
—
cases:0.00%
controls:0.26%
—
—
—
—
—
—
—
—
cases:0.00%
controls:1.18%
—
0
5
191
1901
—
—
—
—
0
21
180
1754
loperamide; oral
A07DA03 [21600646]
1.7e+00
—
—
—
—
—
—
cases:2.62%
controls:0.47%
—
—
—
—
—
—
—
—
—
—
—
—
5
9
186
1897
—
—
—
—
—
—
fluocortolone
C05AA08 [21601612]
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.26%
—
—
—
—
—
—
—
0
5
190
1887
—
Other stressful life events affecting family and household
Z63.7 [45537662]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.28%
—
—
—
—
—
—
0
5
180
1770
Familial hypercholesterolaemia
E78.00 [2000501513]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.31%
—
—
—
—
—
—
—
—
—
—
—
—
0
6
191
1900
—
—
—
—
—
—
naproxen; oral, rectal
M01AE02 [21603968]
1.6e-01
1.6e-01
-1.0e+50
—
—
7.0e-01
3.5e-01
cases:10.47%
controls:9.02%
cases:3.66%
controls:3.15%
cases:0.00%
controls:0.31%
—
—
—
—
cases:5.26%
controls:2.70%
cases:11.11%
controls:8.11%
20
172
171
1734
7
60
184
1846
0
6
191
1900
—
—
10
51
180
1841
20
144
160
1631
Overnight pulse oximetry
252568001 [4091874]
—
-1.0e+50
—
—
—
—
—
—
—
cases:0.00%
controls:0.26%
—
—
—
—
—
—
—
—
—
—
—
0
5
191
1901
—
—
—
—
—
Type 1 diabetes mellitus, With other specified complications
E10.6 [45537959]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.28%
—
—
—
—
—
—
0
5
180
1770
Dust mix specific IgE antibody measurement
849121000000107 [44813793]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.28%
—
—
—
—
—
—
0
5
180
1770
Other chest pain
R07.3 [45597166]
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.26%
—
—
—
—
—
—
—
0
5
190
1887
—
Oxygen capacity [Volume Fraction] in Arterial blood
59275-8 [40762366]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.26%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
191
1901
—
—
—
—
—
—
Albumin [Mass/volume] in Serum or Plasma
1751-7 [3024561]
5.3e-01
—
-1.0e+50
—
—
—
7.4e-01
cases:4.71%
controls:2.83%
—
—
cases:0.00%
controls:0.37%
—
—
—
—
—
—
cases:8.89%
controls:4.45%
9
54
182
1852
—
0
7
191
1899
—
—
—
16
79
164
1696
Chronic obstructive pulmonary disease with acute exacerbation, unspecified
J44.1 [45601132]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.45%
—
—
—
—
—
—
0
8
180
1767
Vaginal symptom/complaint other
X15 [2002001300]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.26%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
191
1901
—
—
—
—
—
—
Bicarbonate [Moles/volume] standard in Arterial blood
19230-2 [3014218]
-1.0e+50
—
—
—
—
—
-1.0e+50
cases:0.00%
controls:0.31%
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.34%
0
6
191
1900
—
—
—
—
—
0
6
180
1769
Allergic rhinitis due to pollen
J30.10 [2000502594]
—
-1.0e+50
—
—
—
—
—
—
—
cases:0.00%
controls:0.42%
—
—
—
—
—
—
—
—
—
—
—
0
8
191
1898
—
—
—
—
—
Bacteria [#/volume] in Urine by Culture
100906-7 [1761482]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.34%
—
—
—
—
—
—
0
6
180
1769
medroxyprogesterone; oral, parenteral
G03DA02 [21602540]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.28%
—
—
—
—
—
—
0
5
180
1770
chloramphenicol
S03AA08 [21605197]
-2.2e-03
—
—
—
—
—
2.1e-01
cases:4.71%
controls:4.72%
—
—
—
—
—
—
—
—
—
—
cases:7.78%
controls:6.42%
9
90
182
1816
—
—
—
—
—
14
114
166
1661
Methemoglobin/Hemoglobin.total in Blood
2614-6 [3007930]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.56%
—
—
—
—
—
—
0
10
180
1765
s-atenolol; oral
C07AB11 [21601693]
—
-1.0e+50
—
—
—
-1.0e+50
-1.0e+50
—
—
cases:0.00%
controls:0.37%
—
—
—
—
—
—
cases:0.00%
controls:0.32%
cases:0.00%
controls:0.39%
—
0
7
191
1899
—
—
—
0
6
190
1886
0
7
180
1768
cefuroxime; oral, parenteral
J01DC02 [21602884]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:1.01%
—
—
—
—
—
—
0
18
180
1757
Vomiting
D10 [2002000309]
—
-1.0e+50
—
—
—
—
—
—
—
cases:0.00%
controls:0.42%
—
—
—
—
—
—
—
—
—
—
—
0
8
191
1898
—
—
—
—
—
metoprolol and felodipine
C07FB02 [21601742]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.39%
—
—
—
—
—
—
0
7
180
1768
Cathetrisation of vein
TPH04 [2001309597]
—
—
—
—
—
—
9.4e-02
—
—
—
—
—
—
—
—
—
—
—
—
cases:2.78%
controls:2.54%
—
—
—
—
—
—
5
45
175
1730
Lymphocytes [#/volume] in Blood
26474-7 [3019198]
3.3e-02
-5.3e-02
-1.0e+50
—
—
—
1.2e-01
cases:4.71%
controls:4.56%
cases:3.14%
controls:3.31%
cases:0.00%
controls:0.94%
—
—
—
—
—
—
cases:8.33%
controls:7.44%
9
87
182
1819
6
63
185
1843
0
18
191
1888
—
—
—
15
132
165
1643
scopolamine; oral, parenteral
N05CM05 [21604666]
-1.0e+50
—
—
—
—
—
5.8e-01
cases:0.00%
controls:0.42%
—
—
—
—
—
—
—
—
—
—
cases:2.78%
controls:1.58%
0
8
191
1898
—
—
—
—
—
5
28
175
1747
Medical observation and evaluation for suspected diseases and conditions, ruled out
Z03 [45552058]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.47%
—
—
—
—
—
—
—
—
—
—
—
—
0
9
191
1897
—
—
—
—
—
—
Place of Employment-Worksite
18 [581475]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.45%
—
—
—
—
—
—
0
8
180
1767
Bicarbonate [Moles/volume] standard in Venous blood
19232-8 [3007628]
-1.0e+50
-1.0e+50
—
—
—
-1.0e+50
—
cases:0.00%
controls:0.79%
cases:0.00%
controls:0.42%
—
—
—
—
—
—
cases:0.00%
controls:0.48%
—
—
0
15
191
1891
0
8
191
1898
—
—
—
0
9
190
1883
—
betamethasone
A07EA04 [21600656]
4.3e-01
7.0e-01
-1.0e+50
—
—
—
3.2e-01
cases:5.76%
controls:3.83%
cases:2.62%
controls:1.31%
cases:0.00%
controls:0.26%
—
—
—
—
—
—
cases:7.78%
controls:5.75%
11
73
180
1833
5
25
186
1881
0
5
191
1901
—
—
—
14
102
166
1673
azithromycin; oral, parenteral
J01FA10 [21602978]
4.9e-01
8.2e-01
-1.0e+50
—
—
8.9e-01
3.7e-02
cases:15.71%
controls:10.23%
cases:5.76%
controls:2.62%
cases:0.00%
controls:0.37%
—
—
—
—
cases:6.32%
controls:2.70%
cases:8.33%
controls:8.06%
30
195
161
1711
11
50
180
1856
0
7
191
1899
—
—
12
51
178
1841
15
143
165
1632
Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
10886-0 [3005013]
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.53%
—
—
—
—
—
—
—
0
10
190
1882
—
ethinylestradiol; oral
L02AA03 [21603817]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.28%
—
—
—
—
—
—
0
5
180
1770
clobetasone
D07AB01 [21602105]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.28%
—
—
—
—
—
—
0
5
180
1770
telmisartan; oral
C09CA07 [21601830]
—
—
-1.0e+50
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.26%
—
—
—
—
—
—
—
—
—
—
0
5
191
1901
—
—
—
—
Clinical photography of mouth and teeth
SBB00 [2001310298]
—
-1.0e+50
—
—
—
-1.0e+50
-1.0e+50
—
—
cases:0.00%
controls:0.26%
—
—
—
—
—
—
cases:0.00%
controls:0.26%
cases:0.00%
controls:1.01%
—
0
5
191
1901
—
—
—
0
5
190
1887
0
18
180
1757
Dysphagia
R13 [45573013]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.34%
—
—
—
—
—
—
0
6
180
1769
Haemorrhoids
K96 [2002000623]
-1.0e+50
—
—
—
—
—
-1.0e+50
cases:0.00%
controls:0.26%
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.45%
0
5
191
1901
—
—
—
—
—
0
8
180
1767
estradiol; nasal, oral, parenteral, rectal, transdermal, vaginal
G03CA03 [21602517]
3.3e-01
4.0e-01
—
—
—
4.9e-01
6.0e-01
cases:5.76%
controls:4.20%
cases:4.71%
controls:3.20%
—
—
—
—
—
—
cases:5.26%
controls:3.28%
cases:8.33%
controls:4.73%
11
80
180
1826
9
61
182
1845
—
—
—
10
62
180
1830
15
84
165
1691
Dyspnoea
R06.0 [45558449]
8.5e-01
—
—
—
—
—
—
cases:3.14%
controls:1.36%
—
—
—
—
—
—
—
—
—
—
—
—
6
26
185
1880
—
—
—
—
—
—
12 lead EKG panel
34534-8 [3044889]
3.3e-01
2.0e-01
—
—
—
—
3.2e-01
cases:8.38%
controls:6.19%
cases:4.71%
controls:3.88%
—
—
—
—
—
—
—
—
cases:13.89%
controls:10.48%
16
118
175
1788
9
74
182
1832
—
—
—
—
25
186
155
1589
Optical coherence tomography (OCT) of ocular fundus
CK2X4 [2001301456]
-1.0e+50
—
—
—
—
—
-1.0e+50
cases:0.00%
controls:0.42%
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.39%
0
8
191
1898
—
—
—
—
—
0
7
180
1768
Acute bronchitis, unspecified
J20.9 [45562445]
—
—
—
—
—
—
2.1e-01
—
—
—
—
—
—
—
—
—
—
—
—
cases:2.78%
controls:2.25%
—
—
—
—
—
—
5
40
175
1735
Yersinia sp identified in Stool by Organism specific culture
28549-4 [3014765]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.42%
—
—
—
—
—
—
—
—
—
—
—
—
0
8
191
1898
—
—
—
—
—
—
Maternal care for excessive fetal growth
O36.6 [45543983]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.34%
—
—
—
—
—
—
0
6
180
1769
Dry eye syndrome
H04.10 [2000502254]
-1.0e+50
—
—
—
—
—
-1.0e+50
cases:0.00%
controls:0.42%
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.62%
0
8
191
1898
—
—
—
—
—
0
11
180
1764
Creatinine [Moles/volume] in Urine
14683-7 [3009508]
4.8e-01
—
—
—
-1.0e+50
—
-2.0e-01
cases:3.66%
controls:2.31%
—
—
—
—
—
—
cases:0.00%
controls:0.26%
—
—
cases:5.56%
controls:6.70%
7
44
184
1862
—
—
—
0
5
191
1897
—
10
119
170
1656
almotriptan; oral
N02CC05 [21604380]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.34%
—
—
—
—
—
—
0
6
180
1769
Carbon dioxide [Partial pressure] in Venous blood
2021-4 [3021447]
-1.0e+50
-1.0e+50
—
—
—
-1.0e+50
—
cases:0.00%
controls:0.79%
cases:0.00%
controls:0.52%
—
—
—
—
—
—
cases:0.00%
controls:0.53%
—
—
0
15
191
1891
0
10
191
1896
—
—
—
0
10
190
1882
—
Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
70200-1 [42868674]
—
-1.0e+50
—
—
—
—
—
—
—
cases:0.00%
controls:0.31%
—
—
—
—
—
—
—
—
—
—
—
0
6
191
1900
—
—
—
—
—
salmeterol and fluticasone
R03AK06 [21603280]
—
1.0e+00
-1.0e+50
—
—
—
3.5e-01
—
—
cases:2.62%
controls:0.94%
cases:0.00%
controls:0.31%
—
—
—
—
—
—
cases:2.78%
controls:1.97%
—
5
18
186
1888
0
6
191
1900
—
—
—
5
35
175
1740
dexbrompheniramine, combinations
R06AB56 [21603469]
-1.0e+50
—
—
—
—
—
5.8e-01
cases:0.00%
controls:0.42%
—
—
—
—
—
—
—
—
—
—
cases:2.78%
controls:1.58%
0
8
191
1898
—
—
—
—
—
5
28
175
1747
Urinalysis macro (dipstick) panel - Urine
24357-6 [3037467]
3.8e-01
4.9e-01
—
—
—
5.9e-01
7.1e-01
cases:8.38%
controls:5.88%
cases:5.76%
controls:3.62%
—
—
—
—
—
—
cases:6.32%
controls:3.59%
cases:17.22%
controls:9.24%
16
112
175
1794
11
69
180
1837
—
—
—
12
68
178
1824
31
164
149
1611
Health check-up of pregnant person
SPAT1379 [2001700479]
—
-1.0e+50
—
—
—
-1.0e+50
—
—
—
cases:0.00%
controls:0.26%
—
—
—
—
—
—
cases:0.00%
controls:0.37%
—
—
—
0
5
191
1901
—
—
—
0
7
190
1885
—
Joint ultrasound examination not elsewhere classified
NK4XE [2001308469]
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.26%
—
—
—
—
—
—
—
0
5
190
1887
—
Hematology
82 [38004501]
-1.0e+50
-1.0e+50
—
—
—
-1.0e+50
—
cases:0.00%
controls:0.47%
cases:0.00%
controls:0.42%
—
—
—
—
—
—
cases:0.00%
controls:0.37%
—
—
0
9
191
1897
0
8
191
1898
—
—
—
0
7
190
1885
—
Psoriasis vulgaris
L40.0 [45543370]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.45%
—
—
—
—
—
—
0
8
180
1767
Opening and preparing the root canals, complicated
SGA03 [2001310381]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.58%
—
—
—
—
—
—
—
—
—
—
—
—
0
11
191
1895
—
—
—
—
—
—
Coloscopy
UJF32 [2001305029]
—
—
—
—
—
—
2.9e-01
—
—
—
—
—
—
—
—
—
—
—
—
cases:2.78%
controls:2.08%
—
—
—
—
—
—
5
37
175
1738
Other specified counselling
Z71.8 [45581061]
4.5e-01
—
—
—
—
1.6e+00
2.3e-01
cases:2.62%
controls:1.68%
—
—
—
—
—
—
—
—
cases:3.68%
controls:0.79%
cases:5.56%
controls:4.45%
5
32
186
1874
—
—
—
—
7
15
183
1877
10
79
170
1696
Planned health check-up monitoring, health check-up performed based on individual need
SPAT1317 [2001700418]
—
-1.0e+50
—
—
—
-1.0e+50
—
—
—
cases:0.00%
controls:0.42%
—
—
—
—
—
—
cases:0.00%
controls:0.53%
—
—
—
0
8
191
1898
—
—
—
0
10
190
1882
—
ispaghula (psylla seeds); oral
A06AC01 [21600555]
—
—
—
—
—
—
3.8e-01
—
—
—
—
—
—
—
—
—
—
—
—
cases:3.33%
controls:2.31%
—
—
—
—
—
—
6
41
174
1734
Complement C4 [Mass/volume] in Serum or Plasma
4498-2 [3017766]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.34%
—
—
—
—
—
—
0
6
180
1769
diclofenac
D11AX18 [21602355]
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.48%
—
—
—
—
—
—
—
0
9
190
1883
—
hepatitis B, purified antigen
J07BC01 [21601338]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.52%
—
—
—
—
—
—
—
—
—
—
—
—
0
10
191
1896
—
—
—
—
—
—
Taking care of patient’s/customer’s hygiene
SPAT1137 [2001700238]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.28%
—
—
—
—
—
—
0
5
180
1770
Ophthalmology
18 [38004463]
-3.5e-01
-1.7e-01
-1.0e+50
—
—
—
-4.5e-01
cases:7.85%
controls:10.76%
cases:4.19%
controls:4.93%
cases:0.00%
controls:0.47%
—
—
—
—
—
—
cases:8.33%
controls:12.51%
15
205
176
1701
8
94
183
1812
0
9
191
1897
—
—
—
15
222
165
1553
Nuclear Ab [Titer] in Serum
29953-7 [3037522]
—
-1.0e+50
—
—
—
-1.0e+50
5.4e-01
—
—
cases:0.00%
controls:0.47%
—
—
—
—
—
—
cases:0.00%
controls:0.37%
cases:2.78%
controls:1.63%
—
0
9
191
1897
—
—
—
0
7
190
1885
5
29
175
1746
triamcinolone and antiseptics
D07BB03 [21602150]
2.3e-01
-1.0e+50
—
—
—
—
—
cases:2.62%
controls:2.10%
cases:0.00%
controls:0.58%
—
—
—
—
—
—
—
—
—
—
5
40
186
1866
0
11
191
1895
—
—
—
—
—
ciclesonide; nasal
R01AD13 [43534836]
-1.0e+50
-1.0e+50
—
—
—
—
-1.0e+50
cases:0.00%
controls:0.94%
cases:0.00%
controls:0.63%
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.79%
0
18
191
1888
0
12
191
1894
—
—
—
—
0
14
180
1761
Foreign body in skin
S15 [2002000980]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.39%
—
—
—
—
—
—
0
7
180
1768
midazolam; nasal, oral, parenteral, sublingual
N05CD08 [21604643]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.28%
—
—
—
—
—
—
0
5
180
1770
Surveillance of contraceptive drugs
Z30.4 [45547299]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.26%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
191
1901
—
—
—
—
—
—
Ventricular premature depolarization
I49.3 [45538386]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.39%
—
—
—
—
—
—
0
7
180
1768
nafarelin; nasal
H01CA02 [21602712]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.26%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
191
1901
—
—
—
—
—
—
Female infertility, unspecified
N97.9 [45582432]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.28%
—
—
—
—
—
—
0
5
180
1770
formoterol; inhalant
R03AC13 [21603267]
-1.0e+50
—
—
—
—
—
-1.0e+50
cases:0.00%
controls:0.26%
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.73%
0
5
191
1901
—
—
—
—
—
0
13
180
1762
ondansetron; oral, parenteral, rectal
A04AA01 [21600493]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.39%
—
—
—
—
—
—
0
7
180
1768
Noninvasive ventilation
WX725 [2001310828]
-1.0e+50
-1.0e+50
—
—
—
—
—
cases:0.00%
controls:0.58%
cases:0.00%
controls:0.31%
—
—
—
—
—
—
—
—
—
—
0
11
191
1895
0
6
191
1900
—
—
—
—
—
Otitis externa
H60 [45581713]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.68%
—
—
—
—
—
—
0
12
180
1763
hydrocortisone
D07XA01 [21602180]
2.3e-01
-1.0e+50
—
—
—
—
—
cases:2.62%
controls:2.10%
cases:0.00%
controls:0.58%
—
—
—
—
—
—
—
—
—
—
5
40
186
1866
0
11
191
1895
—
—
—
—
—
telmisartan and diuretics
C09DA07 [21601839]
-1.0e+50
-1.0e+50
—
—
—
-1.0e+50
—
cases:0.00%
controls:0.47%
cases:0.00%
controls:0.37%
—
—
—
—
—
—
cases:0.00%
controls:0.42%
—
—
0
9
191
1897
0
7
191
1899
—
—
—
0
8
190
1884
—
oxcarbazepine; oral
N03AF02 [21604418]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.45%
—
—
—
—
—
—
0
8
180
1767
Type 1 diabetes mellitus, With ketoacidosis
E10.1 [45542735]
-1.0e+50
-1.0e+50
—
—
—
-1.0e+50
-1.0e+50
cases:0.00%
controls:0.47%
cases:0.00%
controls:0.26%
—
—
—
—
—
—
cases:0.00%
controls:0.32%
cases:0.00%
controls:0.62%
0
9
191
1897
0
5
191
1901
—
—
—
0
6
190
1886
0
11
180
1764
Hypodontia
K00.00 [2000502614]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.28%
—
—
—
—
—
—
0
5
180
1770
Extensive health check-up on eighth grade
SPAT1386 [2001700486]
—
-1.0e+50
—
—
—
-1.0e+50
—
—
—
cases:0.00%
controls:0.26%
—
—
—
—
—
—
cases:0.00%
controls:0.37%
—
—
—
0
5
191
1901
—
—
—
0
7
190
1885
—
insulin lispro; parenteral
A10AC04 [21600726]
—
-1.0e+50
-1.0e+50
—
-1.0e+50
-1.0e+50
-1.0e+50
—
—
cases:0.00%
controls:3.41%
cases:0.00%
controls:1.00%
—
—
cases:0.00%
controls:0.74%
cases:0.00%
controls:3.38%
cases:0.00%
controls:4.23%
—
0
65
191
1841
0
19
191
1887
—
0
14
191
1888
0
64
190
1828
0
75
180
1700
Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
12841-3 [3001784]
—
—
—
—
—
—
-2.9e-02
—
—
—
—
—
—
—
—
—
—
—
—
cases:3.89%
controls:4.00%
—
—
—
—
—
—
7
71
173
1704
Pulmonary Disease
29 [38004472]
9.9e-02
—
-1.0e+50
—
—
—
1.6e-02
cases:5.76%
controls:5.25%
—
—
cases:0.00%
controls:0.47%
—
—
—
—
—
—
cases:7.78%
controls:7.66%
11
100
180
1806
—
0
9
191
1897
—
—
—
14
136
166
1639
ofloxacin; oral, parenteral
J01MA01 [21603008]
—
-1.0e+50
—
—
—
—
—
—
—
cases:0.00%
controls:0.26%
—
—
—
—
—
—
—
—
—
—
—
0
5
191
1901
—
—
—
—
—
antibiotics in combination with corticosteroids
D01AA20 [21601918]
—
-1.0e+50
—
—
—
—
—
—
—
cases:0.00%
controls:0.26%
—
—
—
—
—
—
—
—
—
—
—
0
5
191
1901
—
—
—
—
—
Remote contact by phone
ZYC01 [2001311579]
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.26%
—
—
—
—
—
—
—
0
5
190
1887
—
covid-19, RNA-based vaccine
J07BN01 [954934]
9.5e-03
-2.5e-01
-1.0e+50
—
-1.0e+50
1.6e-02
2.5e-02
cases:4.71%
controls:4.67%
cases:3.66%
controls:4.67%
cases:0.00%
controls:0.58%
—
—
cases:0.00%
controls:0.47%
cases:2.63%
controls:2.59%
cases:14.44%
controls:14.14%
9
89
182
1817
7
89
184
1817
0
11
191
1895
—
0
9
191
1893
5
49
185
1843
26
251
154
1524
clindamycin
D10AF01 [21602305]
-1.0e+50
-1.0e+50
—
—
—
-1.0e+50
-1.0e+50
cases:0.00%
controls:0.58%
cases:0.00%
controls:0.26%
—
—
—
—
—
—
cases:0.00%
controls:0.26%
cases:0.00%
controls:0.62%
0
11
191
1895
0
5
191
1901
—
—
—
0
5
190
1887
0
11
180
1764
hydroxychloroquine; oral
P01BA02 [21604889]
-1.0e+50
-1.0e+50
—
—
—
-1.0e+50
—
cases:0.00%
controls:0.52%
cases:0.00%
controls:0.31%
—
—
—
—
—
—
cases:0.00%
controls:0.48%
—
—
0
10
191
1896
0
6
191
1900
—
—
—
0
9
190
1883
—
Unspecified diabetes mellitus, without complications
E14.9 [45605408]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.28%
—
—
—
—
—
—
0
5
180
1770
Type 2 diabetes mellitus
E11 [45571656]
3.6e-01
—
—
—
—
—
-4.8e-02
cases:2.62%
controls:1.84%
—
—
—
—
—
—
—
—
—
—
cases:3.33%
controls:3.49%
5
35
186
1871
—
—
—
—
—
6
62
174
1713
Ova and parasites identified in Stool by Light microscopy
10704-5 [3003327]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.26%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
191
1901
—
—
—
—
—
—
Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
95941-1 [36031861]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.62%
—
—
—
—
—
—
0
11
180
1764
Upper respiratory infection acute
R74 [2002000942]
4.8e-01
1.2e+00
—
—
—
6.2e-01
5.7e-01
cases:5.24%
controls:3.31%
cases:4.71%
controls:1.47%
—
—
—
—
—
—
cases:2.63%
controls:1.43%
cases:10.56%
controls:6.25%
10
63
181
1843
9
28
182
1878
—
—
—
5
27
185
1865
19
111
161
1664
Extensive structural and functional ultrasound examination of heart
FM1EE [2001303307]
—
-1.0e+50
—
—
—
—
2.9e-01
—
—
cases:0.00%
controls:0.52%
—
—
—
—
—
—
—
—
cases:2.78%
controls:2.08%
—
0
10
191
1896
—
—
—
—
5
37
175
1738
hydrocortisone and antiinfectives
S03CA04 [21605208]
—
-1.0e+50
—
—
—
—
—
—
—
cases:0.00%
controls:0.52%
—
—
—
—
—
—
—
—
—
—
—
0
10
191
1896
—
—
—
—
—
chlorphenamine, combinations
R06AB54 [21603468]
1.5e-02
—
—
—
—
—
4.0e-01
cases:3.14%
controls:3.10%
—
—
—
—
—
—
—
—
—
—
cases:3.33%
controls:2.25%
6
59
185
1847
—
—
—
—
—
6
40
174
1735
hydroxyzine; oral, parenteral
N05BB01 [21604590]
1.2e+00
—
—
—
—
—
1.6e+00
cases:2.62%
controls:0.79%
—
—
—
—
—
—
—
—
—
—
cases:3.89%
controls:0.85%
5
15
186
1891
—
—
—
—
—
7
15
173
1760
Supervision of normal first pregnancy
Z34.0 [45595500]
-1.0e+50
-1.0e+50
—
—
—
-1.0e+50
—
cases:0.00%
controls:0.37%
cases:0.00%
controls:0.26%
—
—
—
—
—
—
cases:0.00%
controls:0.26%
—
—
0
7
191
1899
0
5
191
1901
—
—
—
0
5
190
1887
—
Otalgia
H92.0 [45596177]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.51%
—
—
—
—
—
—
0
9
180
1766
Erythrocytes [Presence] in Urine by Automated
53292-9 [3041096]
7.1e-01
—
—
—
—
9.3e-01
8.9e-01
cases:3.66%
controls:1.84%
—
—
—
—
—
—
—
—
cases:2.63%
controls:1.06%
cases:8.33%
controls:3.61%
7
35
184
1871
—
—
—
—
5
20
185
1872
15
64
165
1711
Moderate panic disorder
F41.00 [2000501994]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.28%
—
—
—
—
—
—
0
5
180
1770
Functional diarrhoea
K59.1 [45543327]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.39%
—
—
—
—
—
—
0
7
180
1768
After-cataract
H26.4 [45600893]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.51%
—
—
—
—
—
—
0
9
180
1766
dexamethasone
C05AA09 [21601613]
—
-1.0e+50
—
—
—
-1.0e+50
—
—
—
cases:0.00%
controls:0.26%
—
—
—
—
—
—
cases:0.00%
controls:0.26%
—
—
—
0
5
191
1901
—
—
—
0
5
190
1887
—
Type 1 diabetes mellitus
E10 [45576436]
-1.0e+50
—
—
—
—
—
-1.0e+50
cases:0.00%
controls:0.63%
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:1.18%
0
12
191
1894
—
—
—
—
—
0
21
180
1754
Ultrasound examination of paranasal sinuses
SPAT1028 [2001700129]
—
-1.0e+50
—
—
—
—
-1.0e+50
—
—
cases:0.00%
controls:0.31%
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.51%
—
0
6
191
1900
—
—
—
—
0
9
180
1766
Diabetes mellitus arising in pregnancy
O24.4 [45543922]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.62%
—
—
—
—
—
—
0
11
180
1764
cough suppressants and mucolytics
R05FB01 [21603441]
6.1e-02
-1.0e+50
—
—
—
—
—
cases:2.62%
controls:2.47%
cases:0.00%
controls:0.42%
—
—
—
—
—
—
—
—
—
—
5
47
186
1859
0
8
191
1898
—
—
—
—
—
betaxolol; oral
C07AB05 [21601687]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.26%
—
—
—
—
—
—
—
—
—
—
—
—
0
5
191
1901
—
—
—
—
—
—
Central perforation of tympanic membrane
H72.0 [45538342]
-1.0e+50
—
—
—
—
—
—
cases:0.00%
controls:0.31%
—
—
—
—
—
—
—
—
—
—
—
—
0
6
191
1900
—
—
—
—
—
—
Teeth/gum disease
D82 [2002000380]
5.8e-02
6.7e-01
—
—
—
1.0e+00
-5.7e-01
cases:4.71%
controls:4.46%
cases:3.14%
controls:1.63%
—
—
—
—
—
—
cases:3.68%
controls:1.32%
cases:3.33%
controls:5.75%
9
85
182
1821
6
31
185
1875
—
—
—
7
25
183
1867
6
102
174
1673
Extraction of multiple teeth
EBA15 [2001301927]
—
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.28%
—
—
—
—
—
—
0
5
180
1770
Counselling, unspecified
Z71.9 [45561648]
-1.0e+50
—
—
—
—
—
-1.0e+50
cases:0.00%
controls:0.37%
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.62%
0
7
191
1899
—
—
—
—
—
0
11
180
1764
dutasteride; oral
G04CB02 [21602676]
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.26%
—
—
—
—
—
—
—
0
5
190
1887
—
Lower uterine segment caesarean section
MCA10 [2001306959]
-1.0e+50
—
—
—
—
-1.0e+50
—
cases:0.00%
controls:0.63%
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.42%
—
—
0
12
191
1894
—
—
—
—
0
8
190
1884
—
Sexual health counselling
SPAT1308 [2001700409]
—
—
—
—
—
-1.0e+50
—
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.42%
—
—
—
—
—
—
—
0
8
190
1884
—
Sprain and strain of cervical spine
S13.4 [45573197]
—
—
—
1.0e+50
—
—
—
—
—
—
—
—
—
cases:5.76%
controls:0.00%
—
—
—
—
—
—
—
—
—
11
0
180
1906
—
—
—
Asthma
J45 [45596282]
—
-1.0e+50
—
—
—
—
—
—
—
cases:0.00%
controls:0.37%
—
—
—
—
—
—
—
—
—
—
—
0
7
191
1899
—
—
—
—
—

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
55
348
1.82
3.24
5.6
2.7
—
—
—
0
0
64
435
1.71
2.91
1.3
1.4
9.54
1.57
u/ml
0.47
11
117
9
23
4.05
2.81
1.4
1.1
—
—
—
0
0
93
704
1.63
2.77
8.1
9.0
1.22
1.21
mmol/l
0.64
82
632
8
20
4.13
2.60
1.4
1.1
—
—
—
0
0
84
635
1.58
2.43
3.9
3.0
0.00
0.00
estimate
-0.00
18
130
28
157
1.92
2.37
14.6
14.5
96.75
95.85
%
0.72
28
151
28
158
1.90
2.33
1.1
1.2
—
—
—
0
0
50
339
1.64
2.24
2.1
2.1
2.45
2.82
mg/l
0.75
45
296
61
436
1.59
2.21
4.6
3.5
0.00
0.01
estimate
0.50
24
144
37
234
1.72
2.14
2.9
2.9
2.43
2.44
mmol/l
0.11
32
207
58
413
1.58
2.12
4.1
4.7
—
—
—
0
0
0
58
0.00
2.08
0.0
3.2
—
1272.55
—
0
48
91
720
1.50
2.05
2.7
2.8
—
—
estimate
—
0
0
26
150
1.85
2.03
15.6
13.5
130.96
126.09
g/l
0.52
26
145
21
113
1.96
2.01
17.9
11.0
25.72
25.18
mmol/l
0.33
21
113
29
174
1.79
2.01
14.5
13.4
7.41
7.42
ph
0.30
14
96
5
11
4.63
1.95
1.0
1.2
1.90
1.72
mmol/l
—
5
11
28
173
1.72
1.76
14.9
13.3
5.21
5.13
kpa
0.23
28
166
28
173
1.72
1.76
14.9
13.3
11.37
12.78
kpa
1.41
28
166
175
1624
1.93
1.75
15.9
14.1
23.88
23.60
mg/l
0.04
150
1304
32
209
1.64
1.65
13.7
8.9
103.41
104.53
mmol/l
0.81
32
209
10
42
2.46
1.64
1.1
1.1
0.95
1.37
u/ml
—
5
24
28
177
1.68
1.63
1.3
1.2
—
—
—
0
0
62
472
1.46
1.62
2.7
3.7
2.36
2.36
mmol/l
0.16
56
434
33
219
1.61
1.60
2.3
2.4
—
—
—
0
0
62
474
1.46
1.58
3.0
2.6
0.00
0.00
estimate
-0.00
19
123
24
147
1.72
1.56
16.6
11.7
—
—
—
0
0
5
128
0.37
1.56
1.6
5.4
1.68
40.95
ug/l
—
5
103
30
436
0.63
1.52
3.0
4.3
5.82
7.86
mg/mmol
0.31
18
299
55
415
1.46
1.49
5.0
4.3
92.80
92.18
%
0.07
55
410
100
841
1.40
1.48
4.1
3.4
0.00
0.00
estimate
-0.00
23
151
11
52
2.18
1.47
1.2
1.1
3.11
1.39
u/ml
—
6
30
36
252
1.53
1.40
1.2
1.3
25.70
4.21
u/ml
0.57
15
101
29
194
1.58
1.37
1.2
1.2
—
—
—
0
0
5
17
2.99
1.36
1.0
1.5
—
—
—
0
0
11
54
2.10
1.35
2.8
1.5
—
—
—
0
0
100
851
1.37
1.33
4.1
3.4
0.00
0.00
estimate
-0.00
22
140
63
499
1.39
1.30
1.5
1.5
—
—
—
0
0
98
835
1.36
1.28
4.1
3.3
0.00
0.00
estimate
-0.00
24
151
17
101
1.75
1.24
2.6
5.9
25.11
24.54
mmol/l
0.49
17
101
70
568
1.37
1.24
4.4
4.0
50.37
31.89
e6/l
0.36
60
398
21
133
1.65
1.23
2.2
2.1
0.13
0.00
estimate
—
8
31
77
635
1.36
1.23
7.5
10.5
1.05
1.17
inr
3.33
67
529
62
494
1.38
1.23
4.3
3.3
16.30
37.02
e6/l
0.95
55
377
5
19
2.67
1.22
2.0
1.9
—
—
—
0
0
31
426
0.67
1.19
2.5
3.7
50.61
56.80
mg/l
0.08
17
299
110
961
1.34
1.18
6.0
11.7
4.20
3.95
e9/l
0.50
101
840
16
95
1.75
1.18
5.8
13.1
25.69
24.64
mmol/l
0.84
16
89
5
20
2.54
1.16
1.0
9.7
15.76
11.88
%
—
5
20
49
381
1.38
1.11
4.4
3.2
1.02
1.02
kg/l
0.01
36
240
6
122
0.48
1.09
1.3
1.4
—
—
—
0
0
104
908
1.32
1.09
7.3
6.0
5.91
6.60
mmol/l
7.80
99
864
81
684
1.32
1.08
3.4
3.1
6.23
6.16
ph
0.24
55
384
67
551
1.33
1.07
4.8
7.3
—
—
—
0
0
13
75
1.79
1.05
1.2
2.5
—
—
—
0
0
101
882
1.31
1.04
4.8
7.5
2.12
1.91
e9/l
0.52
94
792
27
190
1.49
1.04
2.2
1.8
—
—
—
0
0
53
423
1.35
1.03
4.5
3.2
0.15
0.30
e6/l
0.82
46
304
87
746
1.31
1.02
7.6
11.1
0.00
0.00
e9/l
0.33
75
603
41
522
0.73
1.01
2.4
3.5
7.92
9.00
mmol/l
0.61
35
471
34
253
1.42
0.99
2.2
2.9
70.21
121.02
ug/g
1.36
26
199
101
887
1.29
0.98
4.6
8.0
0.17
0.19
e9/l
1.00
94
791
98
860
1.29
0.95
4.6
7.4
0.04
0.04
e9/l
0.17
89
754
98
860
1.29
0.95
4.6
7.4
0.56
0.57
e9/l
0.11
89
754
37
286
1.36
0.88
1.4
1.5
—
—
—
0
0
27
198
1.42
0.86
1.4
1.6
—
—
—
0
0
152
1605
0.74
0.86
4.1
4.5
1.38
1.38
mmol/l
0.02
145
1525
32
243
1.38
0.84
3.6
3.0
0.49
2.05
e6/l
1.64
19
109
152
1604
0.74
0.84
4.2
4.5
4.63
4.67
mmol/l
0.23
146
1536
54
445
1.30
0.83
3.2
3.8
7.40
7.39
ph
0.05
45
316
8
47
1.73
0.81
1.0
1.1
—
—
—
0
0
12
74
1.66
0.80
2.3
4.6
0.52
0.63
%
0.64
12
74
144
1527
0.77
0.79
3.7
3.9
1.26
1.34
mmol/l
0.72
135
1445
0
27
0.00
0.78
0.0
1.8
—
—
—
0
0
0
27
0.00
0.78
0.0
1.8
—
—
—
0
0
0
27
0.00
0.78
0.0
1.8
—
—
—
0
0
0
27
0.00
0.78
0.0
1.8
—
—
—
0
0
60
506
1.27
0.77
2.7
2.3
—
—
—
0
0
25
185
1.40
0.77
1.2
1.7
—
—
—
0
0
36
284
1.33
0.75
1.3
1.3
12.08
27.86
iu/ml
1.58
11
80
12
76
1.62
0.73
2.1
2.3
0.60
0.00
estimate
—
5
25
52
434
1.27
0.73
3.2
2.9
—
—
—
0
0
49
407
1.27
0.71
1.3
1.4
2.28
2.43
g/l
0.35
31
262
13
85
1.57
0.71
1.3
1.2
—
—
—
0
0
7
41
1.73
0.70
1.1
1.0
—
—
—
0
0
7
42
1.69
0.69
1.3
17.5
1.14
1.28
mmol/l
—
7
35
13
86
1.55
0.68
3.3
10.4
—
—
—
0
0
16
113
1.45
0.63
2.6
3.9
—
—
—
0
0
9
141
0.62
0.63
2.4
4.3
1.57
1.73
%
—
9
130
27
211
1.33
0.61
2.9
8.5
1.05
1.03
mmol/l
0.15
22
200
0
20
0.00
0.60
0.0
1.2
—
—
—
0
0
0
20
0.00
0.60
0.0
2.4
—
528.00
—
0
13
0
21
0.00
0.60
0.0
4.5
—
20.88
—
0
21
44
369
1.25
0.59
1.8
1.9
0.91
1.12
mg/l
0.23
35
285
0
23
0.00
0.58
0.0
2.4
—
1244.76
—
0
17
0
23
0.00
0.58
0.0
2.3
—
34.39
—
0
23
6
35
1.74
0.58
1.3
2.9
150.33
134.66
g/l
—
6
29
13
90
1.48
0.57
15.4
17.1
18.28
16.64
%
1.35
13
85
8
124
0.63
0.56
1.5
1.5
1.14
1.25
g/l
—
8
116
67
753
0.83
0.56
2.9
2.7
—
—
—
0
0
23
178
1.33
0.56
1.3
1.5
—
—
—
0
0
150
1429
1.23
0.53
16.5
17.1
13.31
13.34
%
0.14
150
1416
20
153
1.34
0.53
3.2
5.5
7.38
7.39
ph
—
10
92
63
557
1.20
0.51
3.5
3.2
23.30
40.37
ng/l
1.12
38
339
34
283
1.25
0.49
4.7
3.2
61.32
351.07
ng/l
1.49
22
194
17
129
1.35
0.47
1.1
1.1
—
—
—
0
0
13
94
1.41
0.47
1.5
1.3
—
—
—
0
0
42
360
1.21
0.47
1.4
1.7
—
—
—
0
0
62
554
1.18
0.44
2.0
1.9
—
—
—
0
0
144
1500
0.84
0.44
4.1
4.2
5.64
5.85
mmol/l
2.10
138
1417
11
78
1.44
0.44
2.4
4.5
1.85
1.59
%
0.30
11
78
56
497
1.18
0.43
5.0
6.4
—
—
—
0
0
5
32
1.58
0.42
2.4
3.2
—
—
—
0
0
5
33
1.53
0.41
1.2
1.1
—
—
—
0
0
5
33
1.53
0.41
1.2
1.6
—
—
—
0
0
0
16
0.00
0.41
0.0
4.6
—
2.40
—
0
16
0
17
0.00
0.41
0.0
1.3
—
—
—
0
0
0
18
0.00
0.40
0.0
3.4
—
43.44
—
0
8
0
18
0.00
0.40
0.0
7.6
—
8.17
—
0
18
0
18
0.00
0.40
0.0
3.8
—
44.44
—
0
18
0
19
0.00
0.39
0.0
8.8
—
0.57
—
0
19
5
76
0.65
0.36
2.2
2.6
19.00
21.84
s
—
5
69
6
46
1.31
0.33
2.2
3.0
7.40
7.42
ph
—
6
46
14
112
1.27
0.29
1.2
1.3
211.31
363.32
u/ml
0.36
14
103
124
1189
1.12
0.29
6.9
8.7
78.61
79.25
u/l
0.05
119
1141
8
67
1.20
0.26
1.0
1.1
—
—
—
0
0
28
246
1.16
0.25
1.5
1.9
—
—
—
0
0
37
407
0.89
0.23
3.6
5.2
—
—
—
0
0
7
95
0.73
0.23
1.0
1.1
—
0.76
—
0
8
0
11
0.00
0.21
0.0
31.8
—
159.55
—
0
11
0
10
0.00
0.21
0.0
2.4
—
0.80
—
0
10
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
0
10
0.00
0.21
0.0
1.1
—
0.72
—
0
5
0
10
0.00
0.21
0.0
2.8
—
32.28
—
0
5
21
183
1.17
0.21
1.5
1.9
3.33
3.58
mmol/l
0.46
14
142
174
1715
1.16
0.18
11.7
11.7
—
—
—
0
0
7
60
1.17
0.18
2.0
2.7
8246.11
5284.16
u/l
—
7
19
7
61
1.15
0.17
2.1
12.7
1.07
0.87
%
—
7
53
5
66
0.75
0.17
1.0
1.3
—
—
—
0
0
8
68
1.18
0.17
2.0
11.7
3.39
1.57
%
—
8
60
8
70
1.15
0.16
2.1
2.2
—
—
—
0
0
10
83
1.22
0.16
1.2
1.6
—
—
—
0
0
8
97
0.82
0.14
1.0
1.1
1.57
1.48
g/l
—
8
97
8
98
0.81
0.14
1.0
1.1
0.87
0.92
g/l
—
8
98
116
1187
0.94
0.12
3.8
3.9
14.94
14.65
pmol/l
0.59
108
1097
60
623
0.95
0.10
5.5
4.2
3.46
2.08
ug/l
0.42
60
563
40
380
1.07
0.10
2.6
2.7
0.52
0.73
ug/l
2.23
26
209
49
469
1.06
0.09
2.7
2.1
—
—
—
0
0
25
233
1.08
0.09
1.6
2.5
14.81
14.46
umol/l
0.08
25
220
14
126
1.12
0.09
2.9
1.7
0.26
0.34
mg/l
—
6
63
6
55
1.09
0.09
12.5
10.0
—
—
—
0
0
16
148
1.09
0.06
1.9
1.8
—
—
—
0
0
50
486
1.04
0.05
2.5
2.6
—
0.33
—
0
6
181
1817
0.93
0.02
21.3
21.0
251.27
248.81
e9/l
0.23
181
1793
148
1488
0.98
0.01
19.4
17.4
336.16
334.90
g/l
1.09
148
1482
16
161
0.99
0.00
1.9
1.8
—
—
—
0
0
30
296
1.02
0.00
1.7
1.7
—
—
—
0
0
20
199
1.01
0.00
1.5
2.5
23.03
24.50
%
0.24
20
193
10
103
0.97
0.00
2.7
5.1
74.20
85.45
ng/l
—
10
93
16
163
0.98
0.00
1.9
1.8
—
—
—
0
0
21
207
1.02
0.00
1.2
1.5
—
—
—
0
0
59
587
1.01
0.00
1.8
1.9
90.69
95.50
pmol/l
0.38
31
313
68
683
0.99
0.00
1.6
1.9
1.50
1.44
mmol/l
0.24
61
593
16
162
0.99
0.00
1.9
1.8
—
—
—
0
0
16
162
0.99
0.00
1.9
1.8
—
—
—
0
0
0
9
0.00
0.00
0.0
1.7
—
—
—
0
0
0
9
0.00
0.00
0.0
2.0
—
1888.33
—
0
9
0
9
0.00
0.00
0.0
1.6
—
27.11
—
0
9
182
1819
1.01
0.00
21.1
20.9
90.94
90.20
fl
1.71
182
1807
0
9
0.00
0.00
0.0
2.4
—
—
—
0
0
0
9
0.00
0.00
0.0
1.7
—
60.78
—
0
9
0
8
0.00
-0.00
0.0
1.4
—
127.25
—
0
8
0
5
0.00
-0.00
0.0
2.0
—
4.14
—
0
5
0
5
0.00
-0.00
0.0
2.0
—
2.62
—
0
5
0
8
0.00
-0.00
0.0
1.5
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
2.0
—
34.00
—
0
5
8
83
0.96
-0.00
1.0
1.1
—
—
—
0
0
8
89
0.89
-0.00
1.1
2.6
—
6.01
—
0
24
5
55
0.91
-0.00
2.6
3.3
25.60
23.89
mmol/l
—
5
55
0
8
0.00
-0.00
0.0
2.4
—
2.75
—
0
8
9
92
0.98
-0.00
3.4
1.7
—
—
—
0
0
0
6
0.00
-0.00
0.0
3.3
—
1.21
—
0
6
0
7
0.00
-0.00
0.0
1.7
—
—
—
0
0
182
1820
1.00
-0.00
21.1
21.0
4.60
4.69
e12/l
1.90
182
1793
0
5
0.00
-0.00
0.0
1.0
—
0.02
—
0
5
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
7.9
—
4.80
—
0
7
0
6
0.00
-0.00
0.0
1.3
—
2.03
—
0
6
182
1820
1.00
-0.00
21.3
21.2
140.24
141.17
g/l
0.38
182
1808
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
182
1820
1.00
-0.00
22.6
21.6
41.42
42.00
%
0.89
182
1805
0
8
0.00
-0.00
0.0
1.1
—
—
—
0
0
7
79
0.88
-0.00
2.1
6.9
—
—
—
0
0
0
7
0.00
-0.00
0.0
2.6
—
1.00
—
0
7
0
6
0.00
-0.00
0.0
1.5
—
49.00
—
0
6
0
7
0.00
-0.00
0.0
1.1
—
90.00
—
0
7
0
8
0.00
-0.00
0.0
5.9
—
—
—
0
0
0
8
0.00
-0.00
0.0
2.3
—
—
—
0
0
182
1820
1.00
-0.00
21.1
20.9
30.63
30.29
pg
2.23
182
1807
182
1821
0.99
-0.00
21.2
21.1
6.85
6.60
e9/l
0.92
182
1790
0
5
0.00
-0.00
0.0
1.0
—
61.60
—
0
5
0
5
0.00
-0.00
0.0
1.0
—
10.88
—
0
5
0
7
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
7
0.00
-0.00
0.0
10.4
—
9.11
—
0
7

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: VWXY20_DIVING_JUMPI_WATER_CAUSI_INJURY_OTHER_DROWN_SUBME – Diving or jumping into water causing injury other than drowning or submersion

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).